Cross-linking	O
of	O
CD44	B-protein
on	O
rheumatoid	B-cell_type
synovial	I-cell_type
cells	I-cell_type
up-regulates	O
VCAM-1	B-protein
.	O

CD44	O
is	O
a	O
ubiquitous	O
molecule	O
also	O
known	O
as	O
hyaluronic	O
acid	O
or	O
homing	O
receptor	O
.	O

However	O
,	O
the	O
cellular	O
functions	O
and	O
its	O
role	O
in	O
inflammation	O
,	O
for	O
example	O
,	O
rheumatoid	O
synovitis	O
,	O
are	O
currently	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
propose	O
a	O
novel	O
function	O
for	O
CD44	O
.	O

Using	O
synovial	O
cells	O
from	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
patients	O
,	O
we	O
demonstrated	O
that	O
CD44	O
cross-linking	O
and	O
binding	O
to	O
hyaluronan	O
augmented	O
VCAM-1	B-protein
expression	O
and	O
subsequently	O
VCAM-1	B-protein
-mediated	O
cell	O
adhesion	O
.	O

Briefly	O
,	O
we	O
found	O
that	O
1	O
)	O
rheumatoid	B-cell_type
synovial	I-cell_type
cells	I-cell_type
highly	O
expressed	O
CD44	B-protein
;	O
2	O
)	O
cross-linking	O
of	O
CD44	B-protein
markedly	O
but	O
transiently	O
augmented	O
VCAM-1	B-protein
expression	O
and	O
its	O
mRNA	O
transcription	O
much	O
more	O
than	O
did	O
IL-1beta	B-protein
and	O
TNF-alpha	O
;	O
3	O
)	O
hyaluronan	O
,	O
especially	O
when	O
fragmented	O
,	O
also	O
up-regulated	O
VCAM-1	B-protein
;	O
4	O
)	O
CD44	B-protein
activated	O
the	O
transcription	O
factor	O
AP-1	O
;	O
and	O
5	O
)	O
the	O
integrin	B-protein
-dependent	O
adhesive	O
function	O
of	O
RA	B-cell_type
synovial	I-cell_type
cells	I-cell_type
to	O
T	B-cell_type
cells	I-cell_type
was	O
also	O
amplified	O
by	O
CD44	B-protein
cross-linking	O
.	O

These	O
results	O
indicate	O
that	O
the	O
adhesion	O
of	O
RA	B-cell_type
synovial	I-cell_type
cells	I-cell_type
to	O
matrices	O
such	O
as	O
hyaluronic	O
acid	O
through	O
CD44	B-protein
could	O
up-regulate	O
VCAM-1	B-protein
expression	O
and	O
VCAM-1	B-protein
-mediated	O
adhesion	O
to	O
T	B-cell_type
cells	I-cell_type
,	O
which	O
might	O
in	O
turn	O
cause	O
activation	O
of	O
T	B-cell_type
cells	I-cell_type
and	O
synovial	B-cell_type
cells	I-cell_type
in	O
RA	O
synovitis	O
.	O

We	O
therefore	O
propose	O
that	O
such	O
cross-talking	O
among	O
distinct	O
adhesion	O
molecules	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
inflammation	O
,	O
including	O
RA	O
synovitis	O
.	O

'	NULL
9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MicroVue	NULL
Jim	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
CS5a	NULL
,	NULL
at	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
I	NULL
QUIDEL	NULL
MULTIPLE	NULL
<	NULL
‘	NULL
For	NULL
Research	NULL
Use	NULL
Only	NULL
Suu	NULL
s	NULL
``	NULL
``	NULL
V	NULL
2	NULL
``	NULL
#	NULL
s	NULL
meTournal	NULL
-	NULL
Cross-Linking	NULL
of	NULL
CD44	NULL
on	NULL
Rheumatoid	NULL
Aﬁlliilmunélo	NULL
gy	NULL
Synovial	NULL
Cells	NULL
Up-Regulates	NULL
VCAM-1	NULL
Koichi	NULL
Fujii	NULL
,	NULL
Yoshiya	NULL
Tanaka	NULL
,	NULL
Stefan	NULL
Hubscher	NULL
,	NULL
Kazuyoshi	NULL
20	NULL
.	NULL

2	NULL
.	NULL

Saito	NULL
,	NULL
Toshiyuki	NULL
Ot	NULL
d	NULL
Sumiya	NULL
Et	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
arto	NULL
,	NULL
ZosmtyU	NULL
a	NULL
and	NULL
»	NULL
umiya	NULL
HtO	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:2391-2398	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/4/2391	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
51	NULL
articles	NULL
,	NULL
22	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/4/2391	NULL
full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Cross-Linking	NULL
of	NULL
CD44	NULL
on	NULL
Rheumatoid	NULL
Synovial	NULL
Cells	NULL
Up-Regulates	NULL
VCAM-1	NULL
'	NULL
!	NULL

Koichi	NULL
Fujii	NULL
,	NULL
*	NULL
Yoshiya	NULL
Tanaka	NULL
,	NULL
``	NULL
*	NULL
Stefan	NULL
Hubscher	NULL
,	NULL
``	NULL
Kazuyoshi	NULL
Saito	NULL
,	NULL
*	NULL
Toshiyuki	NULL
Ota	NULL
,	NULL
``	NULL
and	NULL
Sumiya	NULL
Eto*	NULL
CD44	NULL
is	NULL
a	NULL
ubiquitous	NULL
molecule	NULL
also	NULL
known	NULL
as	NULL
hyaluronic	NULL
acid	NULL
or	NULL
homing	NULL
receptor	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cellular	NULL
functions	NULL
and	NULL
its	NULL
role	NULL
in	NULL
inflammation	NULL
,	NULL
for	NULL
example	NULL
,	NULL
rheumatoid	NULL
synovitis	NULL
,	NULL
are	NULL
currently	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
propose	NULL
a	NULL
novel	NULL
function	NULL
for	NULL
CD44	NULL
.	NULL

Using	NULL
synovial	NULL
cells	NULL
from	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
patients	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
CD44	NULL
cross-linking	NULL
and	NULL
binding	NULL
to	NULL
hyaluronan	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
and	NULL
subsequently	NULL
VCAM-1-mediated	NULL
cell	NULL
adhesion	NULL
.	NULL

Briefly	NULL
,	NULL
we	NULL
found	NULL
that	NULL
1	NULL
)	NULL
rheumatoid	NULL
synovial	NULL
cells	NULL
highly	NULL
expressed	NULL
CD44	NULL
;	NULL
2	NULL
)	NULL
cross-linking	NULL
of	NULL
CD44	NULL
markedly	NULL
but	NULL
transiently	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
and	NULL
its	NULL
mRNA	NULL
transcription	NULL
much	NULL
more	NULL
than	NULL
did	NULL
IL-1§	NULL
and	NULL
TNF-a	NULL
;	NULL
3	NULL
)	NULL
hyaluronan	NULL
,	NULL
especially	NULL
when	NULL
fragmented	NULL
,	NULL
also	NULL
up-regulated	NULL
VCAM-1	NULL
;	NULL
4	NULL
)	NULL
CD44	NULL
activated	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
;	NULL
and	NULL
5	NULL
)	NULL
the	NULL
integrin-dependent	NULL
adhesive	NULL
function	NULL
of	NULL
RA	NULL
synovial	NULL
cells	NULL
to	NULL
T	NULL
cells	NULL
was	NULL
also	NULL
amplified	NULL
by	NULL
CD44	NULL
cross-linking	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
adhesion	NULL
of	NULL
RA	NULL
synovial	NULL
cells	NULL
to	NULL
matrices	NULL
such	NULL
as	NULL
hyaluronic	NULL
acid	NULL
through	NULL
CD44	NULL
could	NULL
up-regulate	NULL
VCAM-1	NULL
expression	NULL
and	NULL
VCAM-1-mediated	NULL
adhesion	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
might	NULL
in	NULL
turn	NULL
cause	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
synovial	NULL
cells	NULL
in	NULL
RA	NULL
synovitis	NULL
.	NULL

We	NULL
therefore	NULL
propose	NULL
that	NULL
such	NULL
cross-talking	NULL
among	NULL
distinct	NULL
adhesion	NULL
molecules	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammation	NULL
,	NULL
including	NULL
RA	NULL
synovitis	NULL
.	NULL

2391-2398.	NULL
cytes	NULL
and	NULL
other	NULL
mesenchymal	NULL
cells	NULL
in	NULL
the	NULL
extravascular	NULL
space	NULL
in	NULL
response	NULL
to	NULL
multiple	NULL
stimuli	NULL
.	NULL

Adhesion	NULL
molecules	NULL
play	NULL
a	NULL
fundamental	NULL
role	NULL
in	NULL
inflammatory	NULL
processes	NULL
by	NULL
mediating	NULL
leuko-cyte-endothelial	NULL
cell	NULL
adhesion	NULL
,	NULL
leukocyte	NULL
migration	NULL
,	NULL
and	NULL
T	NULL
cell/	NULL
APC	NULL
interactions	NULL
.	NULL

Ig	NULL
superfamily	NULL
members	NULL
are	NULL
involved	NULL
in	NULL
cell	NULL
adhesion	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
on	NULL
endothelial	NULL
cells	NULL
,	NULL
several	NULL
Ig	NULL
family	NULL
members	NULL
,	NULL
including	NULL
ICAM-1	NULL
,	NULL
ICAM-2	NULL
,	NULL
ICAM-3	NULL
,	NULL
and	NULL
VCAM-1	NULL
,	NULL
are	NULL
recognized	NULL
by	NULL
leukocyte	NULL
integrins	NULL
such	NULL
as	NULL
LFA-1	NULL
and	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

VCAM-1	NULL
is	NULL
highly	NULL
inducible	NULL
by	NULL
several	NULL
inflammatory	NULL
cytokines	NULL
on	NULL
endothelial	NULL
cells	NULL
and	NULL
restricted	NULL
subsets	NULL
of	NULL
APCs	NULL
,	NULL
compared	NULL
with	NULL
a	NULL
lack	NULL
of	NULL
such	NULL
induction	NULL
by	NULL
resting	NULL
endothelial	NULL
cells	NULL
and	NULL
noninflammatory	NULL
tissues	NULL
.	NULL

VCAM-1	NULL
thereby	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
lymphocyte	NULL
migration/infiltration	NULL
and	NULL
lymphocyte	NULL
activation	NULL
by	NULL
APC	NULL
through	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
ligand	NULL
VLA-4	NULL
and/or	NULL
o	NULL
,	NULL
f3	NULL
,	NULL
in	NULL
inflammatory	NULL
processes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
VCAM-1	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
locally	NULL
produced	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
findings	NULL
have	NULL
indicated	NULL
that	NULL
certain	NULL
adhesion	NULL
molecules	NULL
not	NULL
only	NULL
function	NULL
as	NULL
a	NULL
glue	NULL
,	NULL
but	NULL
also	NULL
regulate	NULL
several	NULL
cellular	NULL
functions	NULL
by	NULL
transducing	NULL
signaling	NULL
.	NULL

The	NULL
best-known	NULL
molecules	NULL
are	NULL
I	NULL
nflammation	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
leuko-	NULL
*First	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
and	NULL
*Clinical	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Occupational	NULL
and	NULL
Environmental	NULL
Health	NULL
,	NULL
Japan	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Kitakyushu	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
'Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
,	NULL
United	NULL
Kingdom	NULL
Received	NULL
for	NULL
publication	NULL
March	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
November	NULL
9	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant-in-Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Yoshiya	NULL
Tanaka	NULL
,	NULL
The	NULL
First	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Occupational	NULL
and	NULL
Environmental	NULL
Health	NULL
,	NULL
Japan	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1-1	NULL
Iscigaoka	NULL
,	NULL
Yanatanishi-ku	NULL
,	NULL
Kitakyusyu	NULL
807	NULL
,	NULL
Japan	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
tanaka	NULL
@	NULL
med.uoch-u.ac.jp	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
VLA	NULL
,	NULL
very	NULL
late	NULL
antigen	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
OA	NULL
,	NULL
osteoarthritis	NULL
;	NULL
RA	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
LFA-1	NULL
,	NULL
VLA-4	NULL
,	NULL
CD2	NULL
,	NULL
CD28	NULL
,	NULL
and	NULL
CD154	NULL
,	NULL
which	NULL
induce	NULL
costimu-latory	NULL
signals	NULL
in	NULL
T	NULL
cell/APC	NULL
binding	NULL
via	NULL
multiple	NULL
cellular	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
focal	NULL
adhesion	NULL
kinases	NULL
,	NULL
resulting	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
cytokine	NULL
production	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
the	NULL
engagement	NULL
of	NULL
CD31	NULL
on	NULL
T	NULL
cell	NULL
subsets	NULL
amplified	NULL
integrin-dependent	NULL
adhesion	NULL
to	NULL
endothelial	NULL
ligands	NULL
,	NULL
and	NULL
also	NULL
that	NULL
ICAM-1	NULL
cross-linking	NULL
on	NULL
rheumatoid	NULL
synovial	NULL
cells	NULL
induced	NULL
IL-1	NULL
$	NULL
transcription	NULL
by	NULL
activation	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
AP-1	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
new	NULL
concept	NULL
,	NULL
adhesion	NULL
molecules	NULL
transduce	NULL
certain	NULL
activation	NULL
stimuli	NULL
independent	NULL
of	NULL
cytokine	NULL
stimulation	NULL
.	NULL

This	NULL
has	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
stimulation	NULL
of	NULL
adhesion	NULL
molecules	NULL
also	NULL
up-regulates	NULL
other	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
especially	NULL
VCAM-1	NULL
.	NULL

From	NULL
a	NULL
survey	NULL
of	NULL
cross-linking	NULL
of	NULL
multiple	NULL
adhesion	NULL
molecules	NULL
,	NULL
including	NULL
LFA-1	NULL
,	NULL
VLA-4	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
€D44	NULL
,	NULL
on	NULL
rheumatoid	NULL
synovial	NULL
cells	NULL
(	NULL
a	NULL
typical	NULL
model	NULL
of	NULL
inflammation	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
one	NULL
such	NULL
molecule	NULL
,	NULL
CD44	NULL
,	NULL
was	NULL
unique	NULL
in	NULL
its	NULL
remarkable	NULL
up-regulation	NULL
of	NULL
VCAM-1	NULL
expression	NULL
on	NULL
synovial	NULL
cells	NULL
and	NULL
also	NULL
of	NULL
their	NULL
adhesion	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

CD44	NULL
is	NULL
a	NULL
90-kDa	NULL
transmembrane	NULL
glycoprotein	NULL
widely	NULL
distributed	NULL
on	NULL
T	NULL
lymphocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
monocytes	NULL
,	NULL
fibroblasts	NULL
,	NULL
keratinocytes	NULL
,	NULL
and	NULL
epithelial	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
principal	NULL
known	NULL
ligand	NULL
of	NULL
€D44	NULL
is	NULL
hyaluronan	NULL
(	NULL
12	NULL
)	NULL
.	NULL

CD44	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
multiple	NULL
physiologic	NULL
functions	NULL
,	NULL
including	NULL
cell-cell	NULL
adhesion	NULL
,	NULL
cell-substrate	NULL
interaction	NULL
,	NULL
lymphocyte	NULL
recruitment	NULL
to	NULL
inflammatory	NULL
sites	NULL
,	NULL
and	NULL
tumor	NULL
metastasis	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
function	NULL
of	NULL
CD44	NULL
as	NULL
a	NULL
signaling	NULL
molecule	NULL
has	NULL
also	NULL
been	NULL
dem-onstrated	NULL
.	NULL

Stimulation	NULL
of	NULL
CD44	NULL
with	NULL
mAbs	NULL
or	NULL
hyaluronan	NULL
transmits	NULL
the	NULL
signal	NULL
into	NULL
the	NULL
cells	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
cytokine	NULL
or	NULL
chemokine	NULL
release	NULL
from	NULL
monocytes	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

CD44	NULL
is	NULL
overexpressed	NULL
in	NULL
inflammatory	NULL
sites	NULL
in	NULL
proportion	NULL
to	NULL
the	NULL
intensity	NULL
of	NULL
inflammation	NULL
,	NULL
implicating	NULL
CD44	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

This	NULL
study	NULL
demonstrates	NULL
a	NULL
role	NULL
for	NULL
€D44	NULL
and	NULL
the	NULL
potent	NULL
ligand	NULL
hyaluronan	NULL
in	NULL
VCAM-1	NULL
induction	NULL
on	NULL
rheumatoid	NULL
synovial	NULL
cells	NULL
through	NULL
activation	NULL
of	NULL
a	NULL
nuclear	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

We	NULL
propose	NULL
a	NULL
model	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
adhesion	NULL
molecules	NULL
per	NULL
se	NULL
(	NULL
in	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2392	NULL
this	NULL
study	NULL
,	NULL
CD44	NULL
)	NULL
,	NULL
in	NULL
the	NULL
induction	NULL
or	NULL
amplification	NULL
of	NULL
other	NULL
adhesion	NULL
molecules	NULL
(	NULL
in	NULL
this	NULL
study	NULL
,	NULL
VCAM-1	NULL
)	NULL
on	NULL
the	NULL
same	NULL
cell	NULL
and	NULL
the	NULL
subsequent	NULL
mediation	NULL
of	NULL
cellular	NULL
adhesion	NULL
in	NULL
inflammatory	NULL
processes	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Synovial	NULL
tissues	NULL
and	NULL
culture	NULL
of	NULL
synoviocytes	NULL
Synovial	NULL
tissues	NULL
were	NULL
obtained	NULL
from	NULL
patients	NULL
with	NULL
active	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
osteoarthritis	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
diagnosed	NULL
according	NULL
to	NULL
the	NULL
criteria	NULL
of	NULL
the	NULL
American	NULL
College	NULL
of	NULL
Rheumatology	NULL
,	NULL
(	NULL
Atlanta	NULL
,	NULL
GA	NULL
)	NULL
,	NULL
who	NULL
were	NULL
treated	NULL
by	NULL
joint	NULL
replacement	NULL
surgery	NULL
or	NULL
synovectomy	NULL
.	NULL

The	NULL
synovial	NULL
membrane	NULL
samples	NULL
were	NULL
snap	NULL
frozen	NULL
and	NULL
later	NULL
stained	NULL
for	NULL
immunohistochemical	NULL
stud-ies	NULL
.	NULL

Samples	NULL
were	NULL
also	NULL
dissected	NULL
under	NULL
sterile	NULL
conditions	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
immediately	NULL
prepared	NULL
for	NULL
culture	NULL
of	NULL
fibroblast-like	NULL
synovial	NULL
cells	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
tissue	NULL
sample	NULL
was	NULL
minced	NULL
into	NULL
small	NULL
pieces	NULL
and	NULL
digested	NULL
with	NULL
collagenase	NULL
(	NULL
Sigma	NULL
Aldrich	NULL
Japan	NULL
,	NULL
Tokyo	NULL
)	NULL
in	NULL
serum-free	NULL
DMEM	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

After	NULL
filtering	NULL
through	NULL
a	NULL
nylon	NULL
mesh	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
suspended	NULL
in	NULL
DMEM	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Bio-Pro	NULL
,	NULL
Karlsruhe	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
penicillin-streptomycin	NULL
(	NULL
10	NULL
U/ml	NULL
;	NULL
Sigma	NULL
Aldrich	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
isolated	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
25-cm	NULL
>	NULL
culture	NULL
flasks	NULL
(	NULL
Falcon	NULL
,	NULL
Lincoln	NULL
Park	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
carbon	NULL
dioxide	NULL
atmosphere	NULL
.	NULL

After	NULL
overnight	NULL
culture	NULL
,	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
further	NULL
incubation	NULL
of	NULL
adherent	NULL
cells	NULL
was	NULL
continued	NULL
in	NULL
fresh	NULL
medium	NULL
.	NULL

At	NULL
confluence	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
trypsinized	NULL
,	NULL
passaged	NULL
at	NULL
a	NULL
1:3	NULL
split	NULL
ratio	NULL
,	NULL
and	NULL
recultured	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
changed	NULL
twice	NULL
each	NULL
week	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
used	NULL
after	NULL
three	NULL
to	NULL
seven	NULL
passages	NULL
.	NULL

Reagents	NULL
and	NULL
mAbs	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
Cosmobio	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
were	NULL
purchased	NULL
.	NULL

Fragmented	NULL
and	NULL
native	NULL
hyaluronan	NULL
were	NULL
kindly	NULL
donated	NULL
by	NULL
the	NULL
Tokyo	NULL
Research	NULL
Institute	NULL
of	NULL
Seikagaku	NULL
.	NULL

The	NULL
following	NULL
mAbs	NULL
were	NULL
used	NULL
as	NULL
purified	NULL
Igs	NULL
:	NULL
MHC	NULL
class	NULL
I	NULL
(	NULL
mAb	NULL
W6/32	NULL
)	NULL
,	NULL
CD14	NULL
(	NULL
mAb	NULL
63D3	NULL
)	NULL
,	NULL
anti-glycophorin	NULL
(	NULL
mAb	NULL
10F7	NULL
)	NULL
,	NULL
CD11a	NULL
(	NULL
LFA-1a	NULL
)	NULL
(	NULL
mAb	NULL
TS1/22	NULL
)	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collec-tion	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
,	NULL
control	NULL
(	NULL
mAb	NULL
Thy-1.2	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
mAb	NULL
IVA12	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
D.	NULL
Capra	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
CD19	NULL
(	NULL
mAb	NULL
FMC63	NULL
,	NULL
from	NULL
Dr.	NULL
H.	NULL
Zola	NULL
,	NULL
Bedford	NULL
Park	NULL
,	NULL
Australia	NULL
)	NULL
,	NULL
CD16	NULL
(	NULL
mAb	NULL
3G8	NULL
;	NULL
D.	NULL
Siegal	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
CD11b	NULL
(	NULL
mAb	NULL
NIH11b-1	NULL
)	NULL
,	NULL
CD44	NULL
(	NULL
mAb	NULL
NIH	NULL
44-1	NULL
)	NULL
,	NULL
CD54	NULL
(	NULL
ICAM-1	NULL
)	NULL
(	NULL
mAb	NULL
84H10	NULL
)	NULL
,	NULL
CD49d	NULL
(	NULL
VLA-4	NULL
)	NULL
(	NULL
mAb	NULL
NIH	NULL
49d-1	NULL
,	NULL
gifts	NULL
from	NULL
Dr.	NULL
S.	NULL
Shaw	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
and	NULL
CD106	NULL
(	NULL
mAb	NULL
2G7	NULL
,	NULL
Dr.	NULL
W.	NULL
Newman	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
Highly	NULL
purified	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
from	NULL
PBMC	NULL
of	NULL
healthy	NULL
volunteers	NULL
by	NULL
exhaustive	NULL
immunomagnetic	NULL
negative	NULL
selection	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
9	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

We	NULL
routinely	NULL
used	NULL
Dynabeads	NULL
(	NULL
Dynal	NULL
,	NULL
Fort	NULL
Lee	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
a	NULL
mixture	NULL
of	NULL
mAbs	NULL
against	NULL
MHC	NULL
class	NULL
II	NULL
Ag	NULL
,	NULL
CD19	NULL
,	NULL
CD14	NULL
,	NULL
CD16	NULL
,	NULL
CD11b	NULL
,	NULL
and	NULL
glycophorine	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
CD3	NULL
*	NULL
T	NULL
cell	NULL
subset	NULL
was	NULL
more	NULL
than	NULL
99	NULL
%	NULL
,	NULL
as	NULL
assayed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD44	NULL
Cells	NULL
were	NULL
cultured	NULL
until	NULL
subconfluence	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
NIH	NULL
44-1	NULL
mAb	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
washing	NULL
the	NULL
cells	NULL
three	NULL
times	NULL
,	NULL
1	NULL
ug/ml	NULL
of	NULL
goat	NULL
anti-mouse	NULL
IgG-Fc	NULL
was	NULL
added	NULL
as	NULL
the	NULL
second	NULL
Ab	NULL
for	NULL
CD44	NULL
cross-linking	NULL
.	NULL

Stimulation	NULL
of	NULL
CD44	NULL
by	NULL
hyaluronan	NULL
Cells	NULL
were	NULL
cultured	NULL
until	NULL
subconfluence	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
fragmented	NULL
or	NULL
native	NULL
hyaluronan	NULL
(	NULL
0.1	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
6	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Flow	NULL
microfluorometry	NULL
Staining	NULL
and	NULL
flow-cytometric	NULL
analysis	NULL
of	NULL
synovial	NULL
cells	NULL
were	NULL
conducted	NULL
by	NULL
standard	NULL
procedures	NULL
,	NULL
as	NULL
already	NULL
described	NULL
,	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
specific	NULL
mAbs	NULL
and	NULL
subsequent	NULL
FITC-conjugated	NULL
anti-goat	NULL
IgG	NULL
Ab	NULL
or	NULL
FITC-conjugated	NULL
€CD106	NULL
(	NULL
VCAM-1	NULL
)	NULL
mAb	NULL
at	NULL
saturating	NULL
concentrations	NULL
in	NULL
FACS	NULL
medium	NULL
consisting	NULL
of	NULL
HBSS	NULL
(	NULL
Nissui	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
human	NULL
serum	NULL
albumin	NULL
(	NULL
Green-cross	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
NaN	NULL
,	NULL
(	NULL
Sigma	NULL
Aldrich	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
FACS	NULL
medium	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
with	NULL
FACScan	NULL
.	NULL

Amplification	NULL
of	NULL
the	NULL
mAb	NULL
binding	NULL
was	NULL
provided	NULL
by	NULL
a	NULL
three-decade	NULL
logarithmic	NULL
amplifier	NULL
.	NULL

Quantification	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
Ags	NULL
on	NULL
one	NULL
cell	NULL
was	NULL
performed	NULL
using	NULL
beads	NULL
,	NULL
QIFKIT	NULL
(	NULL
Dako	NULL
Japan	NULL
,	NULL
Kyoto	NULL
)	NULL
.	NULL

VCAM-1	NULL
INDUCTION	NULL
BY	NULL
CD44	NULL
Immunohistochemistry	NULL
of	NULL
synovial	NULL
tissue	NULL
Synovial	NULL
tissue	NULL
samples	NULL
were	NULL
obtained	NULL
after	NULL
total	NULL
joint	NULL
replacement	NULL
from	NULL
five	NULL
patients	NULL
diagnosed	NULL
with	NULL
active	NULL
RA	NULL
according	NULL
to	NULL
the	NULL
criteria	NULL
of	NULL
the	NULL
American	NULL
College	NULL
of	NULL
Rheumatology	NULL
,	NULL
and	NULL
from	NULL
five	NULL
patients	NULL
with	NULL
OA	NULL
as	NULL
controls	NULL
.	NULL

Tissues	NULL
were	NULL
snap	NULL
frozen	NULL
and	NULL
later	NULL
stained	NULL
by	NULL
a	NULL
three-stage	NULL
alkaline	NULL
phosphatase/antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
with	NULL
CD44	NULL
mAb	NULL
and	NULL
CD3	NULL
mAb	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cultured	NULL
RA	NULL
synovial	NULL
cells	NULL
by	NULL
a	NULL
single-step	NULL
isolation	NULL
procedure	NULL
.	NULL

The	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
filters	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

VCAM-1	NULL
cDNA	NULL
and	NULL
B-actin	NULL
cDNA	NULL
(	NULL
donated	NULL
by	NULL
Drs	NULL
.	NULL

A.	NULL
Kitani	NULL
and	NULL
T.	NULL
Matsuyama	NULL
,	NULL
Kagoshima	NULL
,	NULL
Japan	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
°°P	NULL
]	NULL
dCTP	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
subsequently	NULL
performed	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
previously	NULL
reported	NULL
method	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

After	NULL
harvest	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
buffer	NULL
I	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
at	NULL
4°C	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.3	NULL
M	NULL
sucrose	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
containing	NULL
1	NULL
pg/ml	NULL
of	NULL
each	NULL
of	NULL
the	NULL
protease	NULL
inhibitors	NULL
(	NULL
antipain	NULL
,	NULL
aprotinin	NULL
,	NULL
chymostatin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pep-statin	NULL
A	NULL
)	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
buffer	NULL
I	NULL
with	NULL
protease	NULL
inhibitors	NULL
and	NULL
then	NULL
Dounce	NULL
homogenized	NULL
(	NULL
20	NULL
strokes	NULL
;	NULL
Kon-tes	NULL
,	NULL
Vineland	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
microcentrifuged	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
buffer	NULL
II	NULL
with	NULL
protease	NULL
inhibitors	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
300	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
gently	NULL
rocked	NULL
on	NULL
a	NULL
platform	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
30-min	NULL
microcentrifugation	NULL
at	NULL
4°C	NULL
,	NULL
supernatants	NULL
were	NULL
dialyzed	NULL
against	NULL
50	NULL
vol	NULL
of	NULL
buffer	NULL
IH	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
for	NULL
5	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
microcentrifugation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
protein	NULL
concentrations	NULL
in	NULL
the	NULL
supernatants	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
Bradford	NULL
assay	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Briefly	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
preincubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
15	NULL
pl	NULL
of	NULL
a	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
2-ME	NULL
,	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
40	NULL
mM	NULL
NaCl	NULL
)	NULL
containing	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
AP-1	NULL
or	NULL
NF-KB	NULL
binding	NULL
sites	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WJ	NULL
)	NULL
,	NULL
which	NULL
was	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Consensus	NULL
oligonucleotides	NULL
of	NULL
AP-1	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
used	NULL
as	NULL
cold	NULL
competitors	NULL
.	NULL

Adhesion	NULL
assay	NULL
The	NULL
adhesion	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
9	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
synovial	NULL
cells	NULL
were	NULL
applied	NULL
to	NULL
24-well	NULL
culture	NULL
plates	NULL
(	NULL
Nunc	NULL
,	NULL
Roskilde	NULL
,	NULL
Den-mark	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
DMEM	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
sodium	NULL
**Cr	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
T	NULL
cells	NULL
in	NULL
1	NULL
mM	NULL
PMA	NULL
(	NULL
Sigma	NULL
Aldrich	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
relevant	NULL
blocking	NULL
mAb	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
PBS	NULL
with	NULL
0.5	NULL
%	NULL
human	NULL
serum	NULL
albu-min	NULL
:	NULL
nonadherent	NULL
cells	NULL
were	NULL
washed	NULL
off	NULL
completely	NULL
.	NULL

Well	NULL
contents	NULL
were	NULL
lysed	NULL
with	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
(	NULL
Sigma	NULL
Aldrich	NULL
)	NULL
,	NULL
and	NULL
gamma	NULL
emissions	NULL
of	NULL
adherent	NULL
wells	NULL
were	NULL
determined	NULL
.	NULL

Results	NULL
RA	NULL
synovial	NULL
cells	NULL
highly	NULL
expressed	NULL
CD44	NULL
We	NULL
initially	NULL
characterized	NULL
cultured	NULL
synovial	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
synovium	NULL
of	NULL
RA	NULL
patients	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
spindle	NULL
shaped	NULL
and	NULL
grew	NULL
in	NULL
a	NULL
cobblestone	NULL
pattern	NULL
.	NULL

Flow-cytometric	NULL
analysis	NULL
of	NULL
these	NULL
cells	NULL
indicated	NULL
that	NULL
they	NULL
lacked	NULL
macrophage	NULL
markers	NULL
such	NULL
as	NULL
MHC	NULL
class	NULL
II	NULL
Ags	NULL
,	NULL
CD14	NULL
and	NULL
CD11b	NULL
,	NULL
but	NULL
spontaneously	NULL
expressed	NULL
CD44	NULL
and	NULL
ICAM-1	NULL
(	NULL
but	NULL
not	NULL
VCAM-1	NULL
)	NULL
with	NULL
a	NULL
monomodal	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
RA	NULL
synovial	NULL
cells	NULL
represented	NULL
type	NULL
B	NULL
synovial	NULL
fibroblast-like	NULL
cells	NULL
.	NULL

The	NULL
vast	NULL
majority	NULL
of	NULL
synovial	NULL
cells	NULL
highly	NULL
expressed	NULL
CD44	NULL
.	NULL

Two	NULL
prominent	NULL
differences	NULL
between	NULL
synovia	NULL
of	NULL
RA	NULL
and	NULL
OA	NULL
were	NULL
hyperplasia	NULL
of	NULL
the	NULL
RA	NULL
synovial	NULL
lining	NULL
layer	NULL
and	NULL
marked	NULL
accumulation	NULL
of	NULL
mononuclear	NULL
inflammatory	NULL
cells	NULL
around	NULL
both	NULL
subsynovial	NULL
and	NULL
perivascular	NULL
areas	NULL
in	NULL
RA	NULL
tissue	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
studies	NULL
showed	NULL
that	NULL
CD44	NULL
was	NULL
strongly	NULL
expressed	NULL
on	NULL
synoviocytes	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CD14	NULL
MHC	NULL
class	NULL
II	NULL
cell	NULL
number	NULL
i	NULL
i	NULL
ICAM-1	NULL
cell	NULL
number	NULL
£	NULL
R	NULL
b	NULL
4	NULL
1	NULL
10	NULL
100	NULL
-	NULL
1	NULL
100	NULL
-	NULL
100010000	NULL
1	NULL
10	NULL
FIGURE	NULL
1	NULL
.	NULL

Phenotypic	NULL
analysis	NULL
of	NULL
synovial	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
CD11b	NULL
mAb	NULL
(	NULL
NIH	NULL
11b-1	NULL
)	NULL
,	NULL
CD14	NULL
mAb	NULL
(	NULL
63D3	NULL
)	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
mAb	NULL
(	NULL
IVA1	NULL
)	NULL
,	NULL
CD44	NULL
mAb	NULL
(	NULL
NIH	NULL
44-1	NULL
)	NULL
,	NULL
ICAM-1	NULL
mAb	NULL
(	NULL
84H10	NULL
)	NULL
,	NULL
and	NULL
VCAM-1	NULL
mAb	NULL
(	NULL
2G7	NULL
)	NULL
.	NULL

Flow-cytometric	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
FACScan	NULL
.	NULL

Shaded	NULL
area	NULL
represents	NULL
profiles	NULL
of	NULL
Thy-1.2	NULL
mAb	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Histograms	NULL
are	NULL
expressed	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
five	NULL
patients	NULL
.	NULL

000	NULL
10000	NULL
I	NULL
10	NULL
100	NULL
100010000	NULL
and	NULL
weakly	NULL
on	NULL
the	NULL
vessels	NULL
of	NULL
RA	NULL
,	NULL
whereas	NULL
synoviocytes	NULL
of	NULL
OA	NULL
only	NULL
scarcely	NULL
expressed	NULL
CD44	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
marked	NULL
accumulation	NULL
of	NULL
mononuclear	NULL
cells	NULL
,	NULL
most	NULL
of	NULL
which	NULL
were	NULL
CD3-positive	NULL
T	NULL
cells	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
RA	NULL
synovium	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
predominant	NULL
difference	NULL
in	NULL
€D44	NULL
expression	NULL
between	NULL
active	NULL
RA	NULL
and	NULL
OA	NULL
is	NULL
observed	NULL
on	NULL
synoviocytes	NULL
,	NULL
and	NULL
that	NULL
CD44-positive	NULL
cells	NULL
are	NULL
seen	NULL
in	NULL
areas	NULL
rich	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
RA	NULL
synovium	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD44	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
up-regulated	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
To	NULL
characterize	NULL
the	NULL
function	NULL
of	NULL
CD44	NULL
,	NULL
we	NULL
assayed	NULL
the	NULL
cell	NULL
surface	NULL
molecule	NULL
expression	NULL
effects	NULL
of	NULL
CD44	NULL
cross-linking	NULL
using	NULL
a	NULL
specific	NULL
mAb	NULL
and	NULL
second	NULL
cross-linker	NULL
Ab	NULL
.	NULL

Flow	NULL
cytometry	NULL
showed	NULL
that	NULL
VCAM-1	NULL
was	NULL
markedly	NULL
induced	NULL
or	NULL
augmented	NULL
by	NULL
the	NULL
CD44	NULL
cross-linking	NULL
on	NULL
synovial	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
,	NULL
VCAM-1	NULL
was	NULL
only	NULL
slightly	NULL
expressed	NULL
on	NULL
nonstimulated	NULL
synovial	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
CD44	NULL
cross-linking	NULL
significantly	NULL
up-regulated	NULL
VCAM-1	NULL
expression	NULL
,	NULL
whereas	NULL
cross-linking	NULL
of	NULL
control	NULL
anti-VLA-4	NULL
mAb	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

The	NULL
results	NULL
were	NULL
consistent	NULL
in	NULL
five	NULL
patients	NULL
with	NULL
RA	NULL
.	NULL

Time-course	NULL
experiments	NULL
showed	NULL
that	NULL
VCAM-1	NULL
expression	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
reached	NULL
maximum	NULL
levels	NULL
(	NULL
approximately	NULL
a	NULL
10-fold	NULL
increase	NULL
compared	NULL
with	NULL
nonstimulated	NULL
synovial	NULL
cells	NULL
)	NULL
,	NULL
within	NULL
6	NULL
h	NULL
of	NULL
CD44	NULL
cross-linking	NULL
,	NULL
but	NULL
the	NULL
expression	NULL
returned	NULL
to	NULL
almost	NULL
basal	NULL
levels	NULL
after	NULL
24	NULL
h	NULL
of	NULL
incubation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
CD44	NULL
cross-linking	NULL
caused	NULL
a	NULL
marked	NULL
but	NULL
transient	NULL
amplification	NULL
of	NULL
VCAM-1	NULL
expression	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD44	NULL
triggered	NULL
VCAM-1	NULL
mRNA	NULL
transcription	NULL
CD44	NULL
cross-linking	NULL
also	NULL
induced	NULL
transcription	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
in	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

After	NULL
CD44	NULL
cross-linking	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
RA	NULL
synovial	NULL
cells	NULL
,	NULL
and	NULL
specific	NULL
mRNA	NULL
was	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
human	NULL
VCAM-1	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
slightly	NULL
expressed	NULL
VCAM-1	NULL
mRNA	NULL
without	NULL
stimulation	NULL
.	NULL

CD44	NULL
cross-linking	NULL
markedly	NULL
augmented	NULL
VCAM-1	NULL
mRNA	NULL
transcription	NULL
,	NULL
which	NULL
was	NULL
maximal	NULL
within	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
but	NULL
subsequently	NULL
gradually	NULL
diminished	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

CD44	NULL
was	NULL
the	NULL
most	NULL
potent	NULL
stimulator	NULL
of	NULL
VCAM-1	NULL
expression	NULL
among	NULL
surface	NULL
molecules	NULL
and	NULL
cytokines	NULL
In	NULL
the	NULL
next	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
magnitude	NULL
of	NULL
CD44-induced	NULL
VCAM-1	NULL
expression	NULL
with	NULL
that	NULL
induced	NULL
by	NULL
other	NULL
stim-	NULL
2393	NULL
C	NULL
FIGURE	NULL
2	NULL
.	NULL

Immunohistochemical	NULL
studies	NULL
of	NULL
OA	NULL
and	NULL
RA	NULL
synovium	NULL
.	NULL

Synovia	NULL
from	NULL
OA	NULL
patient	NULL
(	NULL
A	NULL
)	NULL
and	NULL
RA	NULL
patient	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
were	NULL
stained	NULL
by	NULL
a	NULL
three-stage	NULL
alkaline	NULL
phosphatase/antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
with	NULL
CD44	NULL
mAb	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
CD3	NULL
mAb	NULL
(	NULL
C	NULL
)	NULL
.	NULL

uli	NULL
,	NULL
including	NULL
several	NULL
cytokines	NULL
and	NULL
cell	NULL
surface	NULL
molecules	NULL
expressed	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

When	NULL
ICAM-1	NULL
,	NULL
LFA-1	NULL
,	NULL
or	NULL
VLA-4	NULL
Ag	NULL
was	NULL
cross-linked	NULL
by	NULL
their	NULL
specific	NULL
mAb	NULL
and	NULL
second	NULL
cross-linker	NULL
Ab	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
was	NULL
unchanged	NULL
or	NULL
slightly	NULL
increased	NULL
,	NULL
whereas	NULL
CD44	NULL
cross-linking	NULL
markedly	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
multiple	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
3	NULL
and	NULL
TNF-a	NULL
,	NULL
which	NULL
are	NULL
well	NULL
known	NULL
to	NULL
exist	NULL
in	NULL
high	NULL
concentrations	NULL
in	NULL
RA	NULL
synovium	NULL
and	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
RA	NULL
synovitis	NULL
,	NULL
had	NULL
much	NULL
less	NULL
effect	NULL
on	NULL
VCAM-1	NULL
expression	NULL
than	NULL
CD44	NULL
cross-linking	NULL
at	NULL
6	NULL
h	NULL
of	NULL
stimulation	NULL
of	NULL
RA	NULL
synovial	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Up-regulation	NULL
of	NULL
VCAM-1	NULL
induced	NULL
by	NULL
these	NULL
cytokines	NULL
took	NULL
24-48	NULL
h	NULL
and	NULL
remained	NULL
still	NULL
slight	NULL
level	NULL
at	NULL
6-h	NULL
stimulation	NULL
by	NULL
cytokines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
kinetic	NULL
studies	NULL
were	NULL
reproducible	NULL
among	NULL
three	NULL
different	NULL
RA	NULL
patients	NULL
.	NULL

Thus	NULL
,	NULL
CD44	NULL
stimulation	NULL
and	NULL
cytokine	NULL
stimulation	NULL
require	NULL
a	NULL
clearly	NULL
different	NULL
kinetics	NULL
,	NULL
namely	NULL
CD44	NULL
functions	NULL
much	NULL
faster	NULL
than	NULL
cytokines	NULL
,	NULL
when	NULL
they	NULL
induce	NULL
VCAM-1	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CD44	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2394	NULL
VCAM-1	NULL
expression	NULL
(	NULL
molecules	NULL
/	NULL
cell	NULL
}	NULL
0	NULL
20000	NULL
i	NULL
40000	NULL
FIGURE	NULL
3	NULL
.	NULL

VCAM-1	NULL
up-regulation	NULL
by	NULL
CD44	NULL
cross-linking	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

Synovia	NULL
were	NULL
obtained	NULL
from	NULL
five	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
and	NULL
synovial	NULL
cells	NULL
were	NULL
isolated	NULL
.	NULL

Cells	NULL
were	NULL
cross-linked	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
;	NULL
anti-CD44	NULL
mAb	NULL
,	NULL
NIH	NULL
44-1	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
;	NULL
and	NULL
anti-	NULL
VLA-4	NULL
mAb	NULL
,	NULL
NIH	NULL
49-d	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
for	NULL
6	NULL
h.	NULL
VCAM-1	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
FACScan	NULL
.	NULL

VCAM-1	NULL
expression	NULL
was	NULL
stimulated	NULL
by	NULL
fragmented	NULL
hyaluronan	NULL
Hyaluronic	NULL
acids	NULL
are	NULL
major	NULL
ligands	NULL
for	NULL
cell	NULL
surface	NULL
CD44	NULL
.	NULL

We	NULL
assessed	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
hyaluronan	NULL
on	NULL
VCAM-1	NULL
expression	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
soluble	NULL
full-length	NULL
hyaluronan	NULL
markedly	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Fragmented	NULL
hyaluronan	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
more	NULL
relevant	NULL
to	NULL
inflammation	NULL
including	NULL
RA	NULL
synovitis	NULL
.	NULL

Of	NULL
several	NULL
hyaluronan	NULL
fragments	NULL
,	NULL
the	NULL
6.9-kDa	NULL
fragment	NULL
had	NULL
the	NULL
most	NULL
marked	NULL
effect	NULL
on	NULL
VCAM-1	NULL
expression	NULL
,	NULL
approximately	NULL
twice	NULL
the	NULL
effect	NULL
of	NULL
native	NULL
hyaluronan	NULL
.	NULL

VCAM-1	NULL
up-regulation	NULL
by	NULL
hyaluronan	NULL
also	NULL
reached	NULL
maximum	NULL
level	NULL
within	NULL
6	NULL
h.	NULL
This	NULL
suggests	NULL
that	NULL
hyaluronan	NULL
,	NULL
especially	NULL
when	NULL
fragmented	NULL
,	NULL
is	NULL
a	NULL
possible	NULL
ligand	NULL
involved	NULL
in	NULL
CD44-mediated	NULL
VCAM-1	NULL
expression	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

AP-1	NULL
activation	NULL
triggered	NULL
by	NULL
cross-linking	NULL
of	NULL
CD44	NULL
We	NULL
also	NULL
examined	NULL
the	NULL
nuclear	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
CD44-mediated	NULL
signaling	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
palindromic	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
element	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
RA	NULL
synovial	NULL
cells	NULL
60	NULL
min	NULL
after	NULL
CD44	NULL
cross-linking	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
RA	NULL
synovial	NULL
cells	NULL
exhibited	NULL
low	NULL
basal	NULL
binding	NULL
to	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotides	NULL
.	NULL

However	NULL
,	NULL
after	NULL
CD44	NULL
cross-linking	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
complex	NULL
of	NULL
nuclear	NULL
ex	NULL
FIGURE	NULL
4	NULL
.	NULL

Histogram	NULL
of	NULL
VCAM-1	NULL
expression	NULL
induced	NULL
by	NULL
CD44	NULL
cross-link	NULL
ing	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
The	NULL
figure	NULL
shows	NULL
one	NULL
representative	NULL
histogram	NULL
of	NULL
VCAM-1	NULL
(	NULL
A-C	NULL
)	NULL
and	NULL
ICAM-1	NULL
(	NULL
D-F	NULL
)	NULL
expression	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
cross-linked	NULL
with	NULL
the	NULL
control	NULL
medium	NULL
(	NULL
A	NULL
and	NULL
D	NULL
)	NULL
,	NULL
anti-CD44	NULL
mAb	NULL
(	NULL
B	NULL
and	NULL
E	NULL
)	NULL
,	NULL
or	NULL
anti-VLA-4	NULL
mAb	NULL
(	NULL
C	NULL
and	NULL
F	NULL
)	NULL
for	NULL
6	NULL
h	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
indicated	NULL
molecules	NULL
was	NULL
analyzed	NULL
by	NULL
FACScan	NULL
.	NULL

Representative	NULL
histograms	NULL
from	NULL
one	NULL
of	NULL
five	NULL
patients	NULL
are	NULL
shown	NULL
.	NULL

VCAM-L	NULL
I	NULL
10	NULL
_	NULL
100	NULL
ICAM-1	NULL
1	NULL
10	NULL
_	NULL
100	NULL
1000	NULL
10000	NULL
1	NULL
10	NULL
_	NULL
100	NULL
1000	NULL
10000	NULL
1	NULL
10	NULL
_	NULL
100	NULL
VCAM-1	NULL
INDUCTION	NULL
BY	NULL
CD44	NULL
VCAM-1	NULL
expression	NULL
(	NULL
molecules	NULL
/	NULL
cell	NULL
)	NULL
40000	NULL
80000	NULL
&	NULL
12h	NULL
B	NULL
Ih	NULL
2h	NULL
3h	NULL
4h	NULL
ramen	NULL
.	NULL

VCAM-1	NULL
,	NULL
ﬂ	NULL
ag	NULL
-	NULL
a	NULL
ue	NULL
FIGURE	NULL
5	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
CD44-triggered	NULL
VCAM-1	NULL
expression	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
RA	NULL
fibroblast-like	NULL
cells	NULL
were	NULL
cross-linked	NULL
with	NULL
10	NULL
ug/tal	NULL
of	NULL
anti-CD44	NULL
mAb	NULL
for	NULL
the	NULL
indicated	NULL
duration	NULL
.	NULL

VCAM-1	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
FACScan	NULL
.	NULL

B	NULL
,	NULL
Time	NULL
course	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
by	NULL
CD44	NULL
cross-linking	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
cross-linked	NULL
with	NULL
10	NULL
ug/tal	NULL
of	NULL
anti-CD44	NULL
mAb	NULL
for	NULL
indicated	NULL
time	NULL
periods	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
collected	NULL
.	NULL

VCAM-1	NULL
mRNA	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
blot-ting	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
RA	NULL
patients	NULL
.	NULL

tracts	NULL
with	NULL
AP-1	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
was	NULL
markedly	NULL
enhanced	NULL
,	NULL
which	NULL
was	NULL
completely	NULL
competed	NULL
away	NULL
by	NULL
excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
.	NULL

Furthermore	NULL
,	NULL
mAb	NULL
specific	NULL
for	NULL
c-jun	NULL
produced	NULL
clearly	NULL
defined	NULL
supershift	NULL
complex	NULL
in	NULL
AP-1/DNA	NULL
complex	NULL
induced	NULL
by	NULL
CD44	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
reproducible	NULL
in	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
CD44	NULL
cross-linking	NULL
results	NULL
in	NULL
a	NULL
specific	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

{	NULL
1000	NULL
10000	NULL
I	NULL
10	NULL
_	NULL
100	NULL
1000	NULL
10000	NULL
1000	NULL
10000	NULL
1	NULL
10	NULL
_	NULL
100	NULL
1000	NULL
10000	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
VCAM-1	NULL
expression	NULL
(	NULL
molecules	NULL
/	NULL
cell	NULL
)	NULL
20000	NULL
40000	NULL
1	NULL
_|	NULL
control	NULL
CD44	NULL
ICAM-1	NULL
LFA-1	NULL
VLA-4	NULL
B	NULL
VCAM-1	NULL
expression	NULL
(	NULL
molecules	NULL
/	NULL
cell	NULL
)	NULL
0	NULL
20000	NULL
40000	NULL
control	NULL
IL-1	NULL
8	NULL
TNF-	NULL
&	NULL
IL-6	NULL
FIGURE	NULL
6	NULL
.	NULL

VCAM-1	NULL
up-regulation	NULL
by	NULL
cross-linking	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
cytokine	NULL
stimulation	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
cross-linked	NULL
with	NULL
10	NULL
ug/ml	NULL
of	NULL
the	NULL
indicated	NULL
mAb	NULL
(	NULL
A	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
of	NULL
the	NULL
indicated	NULL
cytokine	NULL
(	NULL
B	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
VCAM-1	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
FACScan	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
RA	NULL
patients	NULL
.	NULL

CD44	NULL
cross-linking	NULL
augmented	NULL
integrin-mediated	NULL
adhesion	NULL
of	NULL
RA	NULL
synovial	NULL
cell	NULL
to	NULL
T	NULL
cells	NULL
Finally	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
CD44-induced	NULL
VCAM-1	NULL
up-regulation	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
was	NULL
involved	NULL
in	NULL
their	NULL
adhesion	NULL
to	NULL
T	NULL
cells	NULL
using	NULL
three	NULL
different	NULL
RA	NULL
patients	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
adhered	NULL
to	NULL
highly	NULL
purified	NULL
peripheral	NULL
PMA-stimulated	NULL
T	NULL
cells	NULL
without	NULL
any	NULL
stimuli	NULL
.	NULL

However	NULL
,	NULL
stimulation	NULL
of	NULL
synovial	NULL
cells	NULL
by	NULL
CD44	NULL
VCAM-1	NULL
expression	NULL
(	NULL
molecules	NULL
/	NULL
cells	NULL
)	NULL
0	NULL
1000	NULL
2000	NULL
3000	NULL
control	NULL
1.7	NULL
kDa	NULL
6.9	NULL
kDa	NULL
40	NULL
kDa	NULL
native	NULL
FIGURE	NULL
7	NULL
.	NULL

VCAM-1	NULL
up-regulation	NULL
by	NULL
fragmented	NULL
hyaluronan	NULL
stimulation	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
fragmented	NULL
hyaluronan	NULL
for	NULL
6	NULL
h.	NULL
The	NULL
molecular	NULL
mass	NULL
of	NULL
hyaluronan	NULL
fragments	NULL
were	NULL
1.7	NULL
kDa	NULL
,	NULL
6.9	NULL
kDa	NULL
,	NULL
40	NULL
kDa	NULL
,	NULL
and	NULL
native	NULL
.	NULL

VCAM-1	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
FACScan	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
RA	NULL
patients	NULL
.	NULL

2395	NULL
A	NULL
B	NULL
C	NULL
D	NULL
E	NULL
F	NULL
G	NULL
H	NULL
I	NULL
J	NULL
e	NULL
``	NULL
aAr1	NULL
U0	NULL
-	NULL
w	NULL
-	NULL
when	NULL
``	NULL
g	NULL
Lfificmmas	NULL
.	NULL

Acs	NULL
auth	NULL
stud	NULL
C	NULL
FIGURE	NULL
8	NULL
.	NULL

EMSA	NULL
for	NULL
determination	NULL
of	NULL
transcription	NULL
factors	NULL
activated	NULL
by	NULL
cross-linking	NULL
of	NULL
CD44	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
Zares	NULL
A	NULL
and	NULL
F	NULL
)	NULL
,	NULL
or	NULL
cross-linked	NULL
with	NULL
anti-CD44	NULL
mAb	NULL
(	NULL
lanes	NULL
B-E	NULL
and	NULL
G-J	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
collected	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
AP-1	NULL
(	NULL
Zanes	NULL
A-E	NULL
)	NULL
or	NULL
labeled	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
F-JI	NULL
)	NULL
oligonucleotide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
(	NULL
Zane	NULL
C	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lane	NULL
H	NULL
)	NULL
oligonucleotide	NULL
for	NULL
cold	NULL
competition	NULL
and	NULL
mAbs	NULL
specific	NULL
for	NULL
c-fos	NULL
(	NULL
lane	NULL
D	NULL
)	NULL
,	NULL
c-jun	NULL
(	NULL
lane	NULL
E	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
lane	NULL
D	NULL
)	NULL
,	NULL
and	NULL
p65	NULL
(	NULL
lane	NULL
J	NULL
)	NULL
for	NULL
supershift	NULL
analysis	NULL
.	NULL

cross-linking	NULL
for	NULL
12	NULL
h	NULL
resulted	NULL
in	NULL
doubling	NULL
the	NULL
adhesion	NULL
rate	NULL
relative	NULL
to	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Adhesion	NULL
of	NULL
both	NULL
nonstimulated	NULL
and	NULL
CD44-cross-linked	NULL
RA	NULL
synovial	NULL
cells	NULL
to	NULL
PMA-activated	NULL
T	NULL
cells	NULL
was	NULL
significantly	NULL
inhibited	NULL
by	NULL
either	NULL
anti-VLA-4	NULL
or	NULL
anti-LFA-1	NULL
mAbs	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
an	NULL
interesting	NULL
and	NULL
consistent	NULL
tendency	NULL
for	NULL
the	NULL
anti-LFA-1	NULL
mAb	NULL
to	NULL
inhibit	NULL
adhesion	NULL
of	NULL
nonstimulated	NULL
synovial	NULL
cells	NULL
better	NULL
than	NULL
the	NULL
anti-VLA-4	NULL
mAb	NULL
,	NULL
whereas	NULL
the	NULL
anti-VLA-4	NULL
mAb	NULL
more	NULL
effectively	NULL
reduced	NULL
the	NULL
adhesion	NULL
of	NULL
CD44-stimulated	NULL
synovial	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
adhesion	NULL
of	NULL
synovial	NULL
cells	NULL
to	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
integrins	NULL
LFA-1	NULL
and	NULL
VLA-4	NULL
,	NULL
but	NULL
the	NULL
VLA-4/VCAM-1	NULL
pathway	NULL
appeared	NULL
to	NULL
be	NULL
centrally	NULL
involved	NULL
in	NULL
CD44-stimulated	NULL
RA	NULL
synovial	NULL
cells	NULL
.	NULL

Discussion	NULL
Adhesion	NULL
molecules	NULL
are	NULL
fundamental	NULL
to	NULL
mechanisms	NULL
of	NULL
normal	NULL
immunity	NULL
and	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
autoimmune	NULL
diseases	NULL
.	NULL

Definition	NULL
of	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
cellular	NULL
adhesion	NULL
and	NULL
its	NULL
importance	NULL
in	NULL
cell-cell	NULL
and	NULL
cell-matrix	NULL
interactions	NULL
has	NULL
progressed	NULL
during	NULL
the	NULL
last	NULL
decade	NULL
.	NULL

The	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
adhesion	NULL
(	NULL
%	NULL
)	NULL
10	NULL
20	NULL
30	NULL
40	NULL
-	NULL
&	NULL
Abo	NULL
)	NULL
Sooo	NULL
.	NULL

--	NULL
-ao	NULL
Ad	NULL
_	NULL
aoe	NULL
Ab	NULL
m	NULL
anti-VLA4	NULL
Eo	NULL
J	NULL
mAb	NULL
o	NULL
sss	NULL
anti-LFA-1	NULL
|	NULL
[	NULL
--	NULL
-_-_-_-3	NULL
4	NULL
anti-VLA-4	NULL
®	NULL
mAbs	NULL
FIGURE	NULL
9	NULL
.	NULL

Adhesion	NULL
assay	NULL
of	NULL
CD44-cross-linked	NULL
synovial	NULL
cells	NULL
and	NULL
PMA-activated	NULL
T	NULL
cells	NULL
.	NULL

RA	NULL
synovial	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
or	NULL
cross-linked	NULL
with	NULL
CD44	NULL
mAb	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
or	NULL
MHC	NULL
class	NULL
I	NULL
mAb	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
for	NULL
12	NULL
h	NULL
,	NULL
and	NULL
sodium	NULL
**Cr-labeled	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
indicated	NULL
blocking	NULL
mAb	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
different	NULL
experiments	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2396	NULL
adhesion	NULL
molecules	NULL
are	NULL
tightly	NULL
regulated	NULL
by	NULL
several	NULL
cellular	NULL
stimuli	NULL
.	NULL

Cytokines	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
IL-1B	NULL
or	NULL
TNF-a	NULL
,	NULL
which	NULL
are	NULL
abundantly	NULL
produced	NULL
at	NULL
inflammatory	NULL
sites	NULL
,	NULL
contributes	NULL
to	NULL
the	NULL
up-regulation	NULL
of	NULL
Ig-superfamily	NULL
adhesion	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
the	NULL
current	NULL
study	NULL
,	NULL
we	NULL
propose	NULL
a	NULL
new	NULL
concept	NULL
,	NULL
that	NULL
stimulation	NULL
of	NULL
the	NULL
adhesion	NULL
molecule	NULL
CD44	NULL
per	NULL
se	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
VCAM-1	NULL
expression	NULL
.	NULL

We	NULL
deduce	NULL
this	NULL
from	NULL
the	NULL
following	NULL
novel	NULL
findings	NULL
:	NULL
1	NULL
)	NULL
CD44	NULL
cross-linking	NULL
on	NULL
RA	NULL
synovial	NULL
fibroblast-like	NULL
cells	NULL
up-regulated	NULL
VCAM-1	NULL
expression	NULL
,	NULL
more	NULL
and	NULL
faster	NULL
than	NULL
did	NULL
stimulation	NULL
with	NULL
inflammatory	NULL
cytokines	NULL
including	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
;	NULL
2	NULL
)	NULL
fragmented	NULL
hyaluronan	NULL
effectively	NULL
increased	NULL
VCAM-1	NULL
expression	NULL
compared	NULL
with	NULL
native	NULL
hyaluronan	NULL
;	NULL
3	NULL
)	NULL
integrin-dependent	NULL
adhesion	NULL
of	NULL
RA	NULL
synovial	NULL
cells	NULL
to	NULL
PMA-activated	NULL
T	NULL
cells	NULL
was	NULL
markedly	NULL
increased	NULL
by	NULL
the	NULL
CD44	NULL
cross-linking	NULL
on	NULL
synovial	NULL
cells	NULL
;	NULL
and	NULL
4	NULL
)	NULL
CD44	NULL
stimulation	NULL
activated	NULL
the	NULL
nuclear	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
stimulation	NULL
of	NULL
one	NULL
adhesion	NULL
molecule	NULL
up-regulated	NULL
another	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
how	NULL
this	NULL
phenomenon	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
inflammatory	NULL
process	NULL
.	NULL

We	NULL
used	NULL
RA	NULL
synovial	NULL
fibroblast-like	NULL
cells	NULL
,	NULL
because	NULL
RA	NULL
synovium	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
typical	NULL
models	NULL
of	NULL
inflammation	NULL
,	NULL
and	NULL
because	NULL
CD44	NULL
is	NULL
predominantly	NULL
expressed	NULL
on	NULL
RA	NULL
synovial	NULL
cells	NULL
and	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
rheumatoid	NULL
synovitis	NULL
(	NULL
19	NULL
,	NULL
24	NULL
)	NULL
.	NULL

CD44	NULL
is	NULL
found	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
most	NULL
leukocytes	NULL
,	NULL
fibroblasts	NULL
,	NULL
keratinocytes	NULL
,	NULL
and	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
is	NULL
implicated	NULL
in	NULL
multiple	NULL
physiologic	NULL
cellular	NULL
functions	NULL
,	NULL
including	NULL
cell-cell	NULL
and	NULL
cell-matrix	NULL
adhesion	NULL
,	NULL
lymphocyte	NULL
homing	NULL
,	NULL
and	NULL
tumor	NULL
metastasis	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
its	NULL
ligand	NULL
(	NULL
16	NULL
,	NULL
24-27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
function	NULL
of	NULL
CD44	NULL
and	NULL
relevance	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammation	NULL
are	NULL
unknown	NULL
at	NULL
present	NULL
.	NULL

Recent	NULL
reports	NULL
suggest	NULL
that	NULL
CD44	NULL
functions	NULL
not	NULL
just	NULL
as	NULL
an	NULL
adhesion	NULL
molecule	NULL
,	NULL
but	NULL
also	NULL
as	NULL
a	NULL
signaling	NULL
molecule	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
cytokine	NULL
release	NULL
from	NULL
monocytes	NULL
are	NULL
induced	NULL
by	NULL
the	NULL
CD44	NULL
stimulation	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
best-known	NULL
ligand	NULL
for	NULL
CD44	NULL
is	NULL
hyaluronan	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Hyaluronan	NULL
is	NULL
a	NULL
high	NULL
m.w	NULL
.	NULL

linear	NULL
repeating	NULL
disaccharide	NULL
,	NULL
B-o-glucuronyl-B-o-N-acetylglucosamine	NULL
,	NULL
which	NULL
is	NULL
the	NULL
major	NULL
extracellular	NULL
glycos-aminoglycan	NULL
found	NULL
in	NULL
almost	NULL
all	NULL
types	NULL
of	NULL
extracellular	NULL
matrix	NULL
,	NULL
including	NULL
rheumatoid	NULL
synovium	NULL
and	NULL
synovial	NULL
fluids	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

The	NULL
nonaggregated	NULL
form	NULL
of	NULL
hyaluronan	NULL
is	NULL
continuously	NULL
secreted	NULL
into	NULL
the	NULL
joint	NULL
space	NULL
by	NULL
elements	NULL
of	NULL
the	NULL
synovium	NULL
.	NULL

It	NULL
comprises	NULL
the	NULL
major	NULL
macromolecular	NULL
species	NULL
of	NULL
the	NULL
synovial	NULL
fluid	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
unique	NULL
viscoelastic	NULL
properties	NULL
of	NULL
what	NULL
is	NULL
otherwise	NULL
effectively	NULL
a	NULL
simple	NULL
plasma	NULL
dialysate	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Fibroblasts	NULL
in	NULL
the	NULL
synovium	NULL
mainly	NULL
synthesize	NULL
hyaluronan	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
short	NULL
chain	NULL
molecules	NULL
of	NULL
hyaluronan	NULL
in	NULL
arthritic	NULL
synovial	NULL
fluid	NULL
is	NULL
due	NULL
to	NULL
degradation	NULL
after	NULL
synthesis	NULL
rather	NULL
than	NULL
to	NULL
defective	NULL
synthesis	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Activated	NULL
hyaluronidase	NULL
and	NULL
reactive	NULL
oxygen-derived	NULL
radical	NULL
species	NULL
mediate	NULL
damage	NULL
to	NULL
hyaluronan	NULL
in	NULL
inflammatory	NULL
joint	NULL
dis-orders	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
fragmented	NULL
hyaluronan	NULL
(	NULL
34-36	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
high	NULL
molecular	NULL
mass	NULL
hyaluronan	NULL
inhibits	NULL
cellular	NULL
proliferation	NULL
of	NULL
endothelial	NULL
cells	NULL
,	NULL
fi-brocytes	NULL
,	NULL
and	NULL
mitogen-stimulated	NULL
lymphocytes	NULL
,	NULL
whereas	NULL
low	NULL
molecular	NULL
mass	NULL
fragments	NULL
have	NULL
a	NULL
stimulatory	NULL
effect	NULL
.	NULL

Low	NULL
molecular	NULL
mass	NULL
fragments	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
angiogenesis	NULL
,	NULL
an	NULL
important	NULL
feature	NULL
of	NULL
early	NULL
inflammation	NULL
(	NULL
37-41	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
fragmented	NULL
hyaluronan	NULL
was	NULL
more	NULL
effective	NULL
in	NULL
up-regulation	NULL
of	NULL
VCAM-1	NULL
compared	NULL
with	NULL
native	NULL
hyaluronan	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
hyaluronan	NULL
is	NULL
far	NULL
from	NULL
an	NULL
inert	NULL
space	NULL
filler	NULL
,	NULL
but	NULL
has	NULL
an	NULL
important	NULL
role	NULL
in	NULL
biological	NULL
activities	NULL
,	NULL
such	NULL
as	NULL
regulation	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
that	NULL
degraded	NULL
products	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
at	NULL
inflammatory	NULL
sites	NULL
are	NULL
as	NULL
important	NULL
as	NULL
cytokines	NULL
VCAM-1	NULL
INDUCTION	NULL
BY	NULL
CD44	NULL
in	NULL
sustaining	NULL
the	NULL
inflammatory	NULL
process	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
demonstrated	NULL
that	NULL
CD44	NULL
cross-linking	NULL
by	NULL
anti-CD44	NULL
mAb	NULL
was	NULL
more	NULL
effective	NULL
in	NULL
VCAM-1	NULL
up-regulation	NULL
than	NULL
hyaluronan	NULL
stimulation	NULL
.	NULL

Recent	NULL
reports	NULL
suggest	NULL
that	NULL
epitope	NULL
1	NULL
of	NULL
CD44	NULL
(	NULL
NIH	NULL
44-1	NULL
mAb	NULL
binding	NULL
site	NULL
)	NULL
is	NULL
more	NULL
effectively	NULL
involved	NULL
in	NULL
CD44-induced	NULL
cell-cell	NULL
adhesion	NULL
than	NULL
the	NULL
epitope	NULL
2	NULL
(	NULL
hyaluronan	NULL
binding	NULL
site	NULL
)	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

The	NULL
different	NULL
ability	NULL
in	NULL
VCAM-1	NULL
up-regulation	NULL
between	NULL
CD44	NULL
mAb	NULL
and	NULL
hyaluronan	NULL
might	NULL
result	NULL
from	NULL
the	NULL
difference	NULL
of	NULL
stimulated	NULL
epitope	NULL
.	NULL

Adhkesion	NULL
molecules	NULL
play	NULL
a	NULL
fundamental	NULL
role	NULL
in	NULL
many	NULL
diverse	NULL
immunologic	NULL
functions	NULL
,	NULL
especially	NULL
Ag	NULL
presentation	NULL
,	NULL
recognition	NULL
of	NULL
target	NULL
cells	NULL
by	NULL
effector	NULL
cells	NULL
,	NULL
migration	NULL
and	NULL
retention	NULL
of	NULL
mononuclear	NULL
cells	NULL
,	NULL
and	NULL
signal	NULL
transduction	NULL
leading	NULL
to	NULL
cellular	NULL
activation	NULL
or	NULL
proliferation	NULL
(	NULL
17	NULL
,	NULL
19	NULL
,	NULL
25	NULL
,	NULL
44-46	NULL
)	NULL
.	NULL

VCAM-1	NULL
was	NULL
originally	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
on	NULL
endothelium	NULL
,	NULL
but	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
VCAM-1	NULL
is	NULL
also	NULL
expressed	NULL
on	NULL
dendritic	NULL
cells	NULL
and	NULL
activated	NULL
macrophages	NULL
,	NULL
and	NULL
that	NULL
cellular	NULL
adhesion	NULL
mediated	NULL
by	NULL
VCAM-1	NULL
and	NULL
ICAM-1	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
VCAM-1	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
synovial	NULL
tissue	NULL
from	NULL
RA	NULL
patients	NULL
:	NULL
1	NULL
)	NULL
VCAM-1	NULL
is	NULL
highly	NULL
detected	NULL
on	NULL
synovial	NULL
intimal	NULL
fibroblast-like	NULL
cells	NULL
,	NULL
vascular	NULL
wall	NULL
cells	NULL
outside	NULL
the	NULL
endothelial	NULL
layer	NULL
,	NULL
scattered	NULL
stromal	NULL
cells	NULL
with	NULL
cytoplasmic	NULL
processes	NULL
,	NULL
and	NULL
cells	NULL
resembling	NULL
fol-licular	NULL
dendritic	NULL
reticulum	NULL
cells	NULL
in	NULL
lymphoid	NULL
aggregates	NULL
with	NULL
germinal	NULL
centers	NULL
;	NULL
2	NULL
)	NULL
there	NULL
is	NULL
a	NULL
marked	NULL
accumulation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
perivascular	NULL
area	NULL
around	NULL
VCAM-1-positive	NULL
synoviocytes	NULL
,	NULL
including	NULL
both	NULL
fibroblast-like	NULL
and	NULL
dendritic-like	NULL
cells	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
prominent	NULL
distinctive	NULL
feature	NULL
of	NULL
the	NULL
cells	NULL
identified	NULL
from	NULL
a	NULL
localized	NULL
region	NULL
of	NULL
pannus	NULL
in	NULL
and	NULL
around	NULL
large	NULL
cartilage	NULL
erosions	NULL
from	NULL
RA	NULL
patients	NULL
is	NULL
their	NULL
abundant	NULL
surface	NULL
display	NULL
of	NULL
VCAM-1	NULL
(	NULL
49	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
adhesion	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
synoviocytes	NULL
or	NULL
endothelium	NULL
through	NULL
VCAM-1	NULL
and	NULL
its	NULL
ligand	NULL
VLA-4	NULL
,	NULL
which	NULL
is	NULL
a	NULL
major	NULL
T	NULL
cell	NULL
integrin	NULL
,	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
interacting	NULL
cells	NULL
(	NULL
both	NULL
T	NULL
cells	NULL
and	NULL
synoviocytes	NULL
)	NULL
and	NULL
further	NULL
release	NULL
of	NULL
cytokines	NULL
and	NULL
degradative	NULL
enzymes	NULL
from	NULL
them	NULL
.	NULL

Furthermore	NULL
,	NULL
CD44	NULL
is	NULL
characteristically	NULL
expressed	NULL
on	NULL
fibroblast-like	NULL
and	NULL
dendritic-like	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
endothelium	NULL
in	NULL
rheumatoid	NULL
synovium	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
concomitant	NULL
expression	NULL
of	NULL
CD44	NULL
and	NULL
VCAM-1	NULL
in	NULL
the	NULL
inflammatory	NULL
pannus	NULL
in	NULL
RA	NULL
and	NULL
our	NULL
current	NULL
report	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
CD44	NULL
by	NULL
cross-linking	NULL
and	NULL
ligation	NULL
by	NULL
fragmented	NULL
hyaluronan	NULL
up-regulated	NULL
VCAM-1	NULL
expression	NULL
on	NULL
rheumatoid	NULL
fibroblast-like	NULL
cells	NULL
and	NULL
increased	NULL
cell	NULL
adhesion	NULL
,	NULL
implicate	NULL
CD44	NULL
in	NULL
an	NULL
important	NULL
role	NULL
in	NULL
synovial	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
implicate	NULL
CD44	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
rheumatoid	NULL
synovial	NULL
inflammation	NULL
and	NULL
articular	NULL
bone	NULL
and	NULL
cartilage	NULL
destruction	NULL
,	NULL
which	NULL
are	NULL
characterized	NULL
by	NULL
the	NULL
accumulation	NULL
and	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
synovial	NULL
cells	NULL
and	NULL
the	NULL
abundant	NULL
production	NULL
of	NULL
cytokines	NULL
and	NULL
degenerative	NULL
enzymes	NULL
.	NULL

The	NULL
VCAM-1	NULL
gene	NULL
promoter	NULL
possesses	NULL
binding	NULL
sites	NULL
for	NULL
two	NULL
major	NULL
nuclear	NULL
transcription	NULL
factors	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Initiation	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
transcription	NULL
induced	NULL
by	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
result	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
51-53	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
CD44	NULL
stimulation	NULL
activated	NULL
AP-1	NULL
,	NULL
but	NULL
not	NULL
NF-KB	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
RA	NULL
synovial	NULL
cells	NULL
,	NULL
and	NULL
confirmed	NULL
this	NULL
by	NULL
EMSA	NULL
.	NULL

Thus	NULL
,	NULL
CD44	NULL
and	NULL
these	NULL
cytokines	NULL
appear	NULL
to	NULL
differentially	NULL
activate	NULL
distinctive	NULL
transcription	NULL
factors	NULL
leading	NULL
to	NULL
transcription	NULL
of	NULL
VCAM-1	NULL
mRNA	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
clear	NULL
difference	NULL
of	NULL
kinetics	NULL
of	NULL
VCAM-1	NULL
up-regulation	NULL
was	NULL
observed	NULL
between	NULL
CD44	NULL
stimulation	NULL
and	NULL
cytokine	NULL
stimulation	NULL
,	NULL
namely	NULL
its	NULL
expression	NULL
reached	NULL
maximum	NULL
level	NULL
within	NULL
6	NULL
h	NULL
by	NULL
CD44	NULL
stimulation	NULL
,	NULL
whereas	NULL
its	NULL
up-regulation	NULL
by	NULL
cytokines	NULL
took	NULL
at	NULL
least	NULL
24	NULL
h	NULL
,	NULL
indicating	NULL
that	NULL
CD44	NULL
may	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
VCAM-1	NULL
expression	NULL
on	NULL
synoviocytes	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Based	NULL
on	NULL
the	NULL
findings	NULL
presented	NULL
in	NULL
this	NULL
work	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
adhesion	NULL
molecules	NULL
may	NULL
induce	NULL
expression	NULL
of	NULL
other	NULL
adhesion	NULL
molecules	NULL
on	NULL
the	NULL
same	NULL
cell	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
we	NULL
observed	NULL
that	NULL
stimulation	NULL
of	NULL
CD44	NULL
by	NULL
cross-linking	NULL
or	NULL
ligation	NULL
with	NULL
fragmented	NULL
hyaluronan	NULL
,	NULL
as	NULL
well	NULL
as	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
augmented	NULL
VCAM-1	NULL
expression	NULL
(	NULL
a	NULL
representative	NULL
inducible	NULL
adhesion	NULL
mole-cule	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
concomitant	NULL
expression	NULL
of	NULL
CD44	NULL
and	NULL
VCAM-1	NULL
on	NULL
inflamed	NULL
RA	NULL
synovial	NULL
cells	NULL
and	NULL
the	NULL
more	NULL
efficient	NULL
induction	NULL
of	NULL
VCAM-1	NULL
by	NULL
CD44	NULL
stimulation	NULL
than	NULL
by	NULL
several	NULL
cytokines	NULL
suggest	NULL
that	NULL
CD44	NULL
could	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
amplification	NULL
of	NULL
VCAM-1	NULL
and	NULL
subsequent	NULL
adhesion	NULL
of	NULL
syonovial	NULL
cells	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
CD44-mediated	NULL
up-regulation	NULL
of	NULL
VCAM-1	NULL
appears	NULL
to	NULL
be	NULL
very	NULL
relevant	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammatory	NULL
diseases	NULL
such	NULL
as	NULL
RA	NULL
synovitis	NULL
.	NULL

Our	NULL
findings	NULL
warrant	NULL
further	NULL
studies	NULL
into	NULL
the	NULL
stimulation	NULL
of	NULL
CD44	NULL
,	NULL
which	NULL
might	NULL
bring	NULL
enormous	NULL
flexibility	NULL
to	NULL
the	NULL
processes	NULL
of	NULL
inflammation	NULL
and	NULL
introduce	NULL
new	NULL
pharmacologic	NULL
approaches	NULL
to	NULL
control	NULL
them	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Ms.	NULL
T.	NULL
Adachi	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
the	NULL
following	NULL
investigators	NULL
and	NULL
an	NULL
institute	NULL
for	NULL
providing	NULL
mAbs	NULL
,	NULL
complementary	NULL
deoxyribonucleic	NULL
acid	NULL
,	NULL
and	NULL
fragmented	NULL
and	NULL
native	NULL
hya-luronan	NULL
:	NULL
Drs	NULL
.	NULL

J.	NULL
D.	NULL
Capra	NULL
,	NULL
A.	NULL
Kitani	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
S.	NULL
Shaw	NULL
,	NULL
D.	NULL
Siegal	NULL
,	NULL
and	NULL
H.	NULL
Zola	NULL
,	NULL
and	NULL
the	NULL
Tokyo	NULL
Research	NULL
Institute	NULL
of	NULL
Seikagaku	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Elices	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
Osborn	NULL
,	NULL
Y.	NULL
Takada	NULL
,	NULL
C.	NULL
Crouse	NULL
,	NULL
S.	NULL
Luhowskyj	NULL
,	NULL
M.	NULL
E.	NULL
Hemler	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Lobb	NULL
.	NULL

1990	NULL
.	NULL

VCAM-1	NULL
on	NULL
activated	NULL
endothelium	NULL
interacts	NULL
with	NULL
the	NULL
leukocyte	NULL
integrin	NULL
VLA-4	NULL
at	NULL
a	NULL
site	NULL
distinct	NULL
from	NULL
the	NULL
VLA-4/fibronectin	NULL
binding	NULL
site	NULL
.	NULL

Cell	NULL
60:577	NULL
.	NULL

2	NULL
.	NULL

Szckanecz	NULL
,	NULL
Z.	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
T.	NULL
R.	NULL
Lin	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
S.	NULL
Goerdt	NULL
,	NULL
G.	NULL
Rayan	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Koch	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
distribution	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecules	NULL
(	NULL
ICAM-1	NULL
,	NULL
ICAM-2	NULL
,	NULL
and	NULL
ICAM-3	NULL
)	NULL
and	NULL
the	NULL
MS-1	NULL
antigen	NULL
in	NULL
normal	NULL
and	NULL
diseased	NULL
human	NULL
synovia	NULL
:	NULL
their	NULL
possible	NULL
pathogenetic	NULL
and	NULL
clinical	NULL
significance	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

37:221	NULL
.	NULL

3	NULL
.	NULL

El-Gablrawy	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
M.	NULL
Gallatin	NULL
,	NULL
R.	NULL
Vazeux	NULL
,	NULL
G.	NULL
Peterman	NULL
,	NULL
and	NULL
J.	NULL
Wilkins	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
ICAM-R	NULL
(	NULL
ICAM-3	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
counter-receptor	NULL
for	NULL
LFA-1	NULL
,	NULL
in	NULL
theu-matoid	NULL
and	NULL
nonrheumatoid	NULL
synovium	NULL
:	NULL
comparison	NULL
with	NULL
other	NULL
adhesion	NULL
mole-cules	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

37:846	NULL
.	NULL

4	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
C.	NULL
Vassallo	NULL
,	NULL
S.	NULL
Luhowskyj	NULL
,	NULL
R.	NULL
G.	NULL
Chi	NULL
,	NULL
and	NULL
R.	NULL
Lobb	NULL
.	NULL

1989	NULL
.	NULL

Direct	NULL
expression	NULL
cloning	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
,	NULL
a	NULL
cytokine-induced	NULL
endothelial	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
59:1203	NULL
.	NULL

5	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Bevilacqua	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
inducible	NULL
endothelial	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
mediates	NULL
melanoma	NULL
adhesion	NULL
.	NULL

Science	NULL
246:1303	NULL
.	NULL

6	NULL
.	NULL

Bednarezyk	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
B.	NULL
W.	NULL
Mcintyre	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
and	NULL
ligand-binding	NULL
function	NULL
of	NULL
the	NULL
integrin	NULL
a	NULL
,	NULL
,	NULL
(	NULL
VLA-4	NULL
)	NULL
on	NULL
neural-crest-derived	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Metastasis	NULL
10:281	NULL
.	NULL

7	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
N.	NULL
D.	NULL
Hall	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Sansom	NULL
.	NULL

1993	NULL
.	NULL

Ligation	NULL
of	NULL
CD28	NULL
receptor	NULL
by	NULL
B7	NULL
induces	NULL
formation	NULL
of	NULL
D-3	NULL
phosphoinositides	NULL
in	NULL
T	NULL
lym-phocytes	NULL
independently	NULL
of	NULL
T	NULL
cell	NULL
receptor/CD3	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:2572	NULL
.	NULL

8	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Bazan	NULL
,	NULL
D.	NULL
Blanchard	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
P.	NULL
Galizzi	NULL
,	NULL
C.	NULL
van	NULL
Kooten	NULL
,	NULL
Y.	NULL
J.	NULL
Liu	NULL
,	NULL
F.	NULL
Rousset	NULL
,	NULL
and	NULL
S.	NULL
Saeland	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
CD40	NULL
antigen	NULL
and	NULL
its	NULL
ligand	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:881	NULL
.	NULL

9	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
M.	NULL
Albelda	NULL
,	NULL
K.	NULL
J.	NULL
Horgan	NULL
,	NULL
G.	NULL
A.	NULL
van	NULL
Seventer	NULL
,	NULL
Y.	NULL
Shimizu	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
J.	NULL
Hallam	NULL
,	NULL
P.	NULL
J.	NULL
Newman	NULL
,	NULL
C.	NULL
A.	NULL
Buck	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1992	NULL
.	NULL

CD31	NULL
expressed	NULL
on	NULL
distinctive	NULL
T	NULL
cell	NULL
subsets	NULL
is	NULL
a	NULL
preferential	NULL
amplifier	NULL
of	NULL
B	NULL
;	NULL
integrin-mediated	NULL
adhesion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:245	NULL
.	NULL

10	NULL
.	NULL

Koyama	NULL
,	NULL
Y.	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
K.	NULL
Saito	NULL
,	NULL
M.	NULL
Abe	NULL
,	NULL
K.	NULL
Nakatsuka	NULL
,	NULL
I.	NULL
Morimoto	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
and	NULL
S.	NULL
Eto	NULL
.	NULL

1996	NULL
.	NULL

Cross-linking	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
CD54	NULL
)	NULL
induces	NULL
AP-1	NULL
activation	NULL
and	NULL
IL-1	NULL
$	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
;	NULL
5097	NULL
.	NULL

11	NULL
.	NULL

Underhill	NULL
,	NULL
C.	NULL
1992	NULL
.	NULL

CD44	NULL
:	NULL
the	NULL
hyaluronan	NULL
receptor	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

103:293	NULL
.	NULL

12	NULL
.	NULL

Aruffo	NULL
,	NULL
A.	NULL
,	NULL
I.	NULL
Stamenkovic	NULL
,	NULL
M.	NULL
Melnick	NULL
,	NULL
C.	NULL
B.	NULL
Underhill	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1990	NULL
.	NULL

CD44	NULL
is	NULL
the	NULL
principal	NULL
cell	NULL
surface	NULL
receptor	NULL
for	NULL
hyaluronate	NULL
.	NULL

Cell	NULL
61:1303	NULL
.	NULL

13	NULL
.	NULL

Jalkanen	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
F.	NULL
Bargatze	NULL
,	NULL
J.	NULL
de	NULL
los	NULL
Toyos	NULL
,	NULL
and	NULL
E.	NULL
C.	NULL
Butcher	NULL
.	NULL

1987	NULL
.	NULL

Lymphocyte	NULL
recognition	NULL
of	NULL
high	NULL
endothelium	NULL
:	NULL
antibodies	NULL
to	NULL
distinct	NULL
epitopes	NULL
of	NULL
an	NULL
85-95	NULL
kD	NULL
glycoprotein	NULL
antigen	NULL
differentially	NULL
inhibit	NULL
lymphocyte	NULL
binding	NULL
to	NULL
lymph	NULL
node	NULL
,	NULL
mucosal	NULL
,	NULL
or	NULL
synovial	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

105:983	NULL
.	NULL

14	NULL
.	NULL

Shimizu	NULL
,	NULL
Y.	NULL
,	NULL
G.	NULL
A.	NULL
van	NULL
Seventer	NULL
,	NULL
R.	NULL
Siraganian	NULL
,	NULL
L.	NULL
Wahl	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1989	NULL
.	NULL

Dual	NULL
role	NULL
of	NULL
the	NULL
CD44	NULL
molecule	NULL
in	NULL
T	NULL
cell	NULL
adhesion	NULL
and	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:2457	NULL
.	NULL

15	NULL
.	NULL

Miyake	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
L.	NULL
Medina	NULL
,	NULL
S.	NULL
Hayashi	NULL
,	NULL
S.	NULL
Ono	NULL
,	NULL
T.	NULL
Hamaoka	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Kincade	NULL
.	NULL

1990	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
Pgp-1/CD44	NULL
block	NULL
lympho-hemopoiesis	NULL
in	NULL
long-term	NULL
bone	NULL
marrow	NULL
cultures	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:477	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

2397	NULL
Gunthert	NULL
,	NULL
U.	NULL
,	NULL
M.	NULL
Hofmann	NULL
,	NULL
W.	NULL
Rudy	NULL
,	NULL
S.	NULL
Reber	NULL
,	NULL
M.	NULL
Zoller	NULL
,	NULL
I.	NULL
Haussmann	NULL
,	NULL
S.	NULL
Maizku	NULL
,	NULL
A.	NULL
Wenzel	NULL
,	NULL
H.	NULL
Ponta	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
new	NULL
variant	NULL
of	NULL
glycoprotein	NULL
CD44	NULL
confers	NULL
metastatic	NULL
potential	NULL
to	NULL
rat	NULL
carcinoma	NULL
cells	NULL
.	NULL

Cell	NULL
65:13	NULL
.	NULL

Webb	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Y.	NULL
Shimizu	NULL
,	NULL
G.	NULL
A.	NULL
van	NULL
Seventer	NULL
,	NULL
S.	NULL
Shaw	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Gerrard	NULL
.	NULL

1990	NULL
.	NULL

LFA-3	NULL
,	NULL
CD44	NULL
,	NULL
and	NULL
CD45	NULL
:	NULL
physiologic	NULL
triggers	NULL
of	NULL
human	NULL
monocyte	NULL
TNF	NULL
and	NULL
IL-1	NULL
release	NULL
.	NULL

Science	NULL
249:1295	NULL
.	NULL

McKee	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Penno	NULL
,	NULL
M.	NULL
Cowman	NULL
,	NULL
M.	NULL
D.	NULL
Burdick	NULL
,	NULL
R.	NULL
M.	NULL
Stricter	NULL
,	NULL
C.	NULL
Bao	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Noble	NULL
.	NULL

1996	NULL
.	NULL

Hyaluronan	NULL
(	NULL
HA	NULL
)	NULL
fragments	NULL
induce	NULL
chemokine	NULL
gene	NULL
expression	NULL
in	NULL
alveolar	NULL
macrophages	NULL
:	NULL
the	NULL
role	NULL
of	NULL
HA	NULL
size	NULL
and	NULL
CD44	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98:2403	NULL
.	NULL

Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
L.	NULL
P.	NULL
Hale	NULL
,	NULL
K.	NULL
L.	NULL
Patton	NULL
,	NULL
M.	NULL
E.	NULL
Martin	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
McCallum	NULL
.	NULL

1991	NULL
.	NULL

Measurement	NULL
of	NULL
an	NULL
adhesion	NULL
molecule	NULL
as	NULL
an	NULL
indicator	NULL
of	NULL
inflammatory	NULL
disease	NULL
activity	NULL
:	NULL
up-regulation	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
hyaluronate	NULL
(	NULL
CD44	NULL
)	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

34:1434	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
D.	NULL
H.	NULL
Adams	NULL
,	NULL
S.	NULL
Hubscher	NULL
,	NULL
H.	NULL
Hirano	NULL
,	NULL
U.	NULL
Sicbenlist	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1993	NULL
.	NULL

T-cell	NULL
adhesion	NULL
induced	NULL
by	NULL
proteoglycan-immobilized	NULL
cytokine	NULL
MIP-1	NULL
.	NULL

Nature	NULL
361:79	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Kimata	NULL
,	NULL
A	NULL
.	NULL

Wake	NULL
,	NULL
S.	NULL
Mince	NULL
,	NULL
L	NULL
Morimoto	NULL
,	NULL
N.	NULL
Yamakawa	NULL
,	NULL
H.	NULL
Habuchi	NULL
,	NULL
S.	NULL
Ashikari	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
K.	NULL
Sakurai	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
S.	NULL
Suzuki	NULL
,	NULL
and	NULL
S.	NULL
Eto	NULL
.	NULL

1996	NULL
.	NULL

Heparan	NULL
sulfate	NULL
proteoglycan	NULL
on	NULL
leukemic	NULL
cells	NULL
is	NULL
primarily	NULL
involved	NULL
in	NULL
integrin	NULL
triggering	NULL
and	NULL
its	NULL
mediated	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1987	NULL
.	NULL

Nakatsuka	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
S.	NULL
Hubscher	NULL
,	NULL
M.	NULL
Abe	NULL
,	NULL
A	NULL
.	NULL

Wake	NULL
,	NULL
K.	NULL
Saito	NULL
,	NULL
I.	NULL
Morimoto	NULL
,	NULL
and	NULL
S.	NULL
Eto	NULL
.	NULL

1997	NULL
.	NULL

Rheumatoid	NULL
synovial	NULL
fibroblasts	NULL
are	NULL
stimulated	NULL
by	NULL
the	NULL
cellular	NULL
adhesion	NULL
to	NULL
T	NULL
cells	NULL
through	NULL
lymphocyte	NULL
function	NULL
associated	NULL
antigen-1/intercellu-lar	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

J.	NULL
Rheumatol	NULL
.	NULL

24:458	NULL
.	NULL

Marlor	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
D.	NULL
L.	NULL
Webb	NULL
,	NULL
M.	NULL
P.	NULL
Bombara	NULL
,	NULL
J.	NULL
M.	NULL
Greve	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Blue	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
in	NULL
fibroblast-like	NULL
synoviocytes	NULL
after	NULL
stimulation	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

140	NULL
;	NULL
1055	NULL
.	NULL

Johnson	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Koch	NULL
.	NULL

1993	NULL
.	NULL

Adhesion	NULL
molecule	NULL
expression	NULL
in	NULL
human	NULL
synovial	NULL
tissue	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

36:137	NULL
.	NULL

Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
M.	NULL
J.	NULL
Telen	NULL
,	NULL
L.	NULL
P.	NULL
Hale	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Denning	NULL
.	NULL

1989	NULL
.	NULL

CD44	NULL
:	NULL
a	NULL
molecule	NULL
involved	NULL
in	NULL
leukocyte	NULL
adherence	NULL
and	NULL
T-cell	NULL
activation	NULL
.	NULL

[	NULL
Published	NULL
erratum	NULL
appears	NULL
in	NULL
1990	NULL
Immunol	NULL
.	NULL

Today	NULL
11:80	NULL
.	NULL
)	NULL

Immunol	NULL
.	NULL

Today	NULL
10:423	NULL
.	NULL

Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

Harden	NULL
,	NULL
M.	NULL
J.	NULL
Telen	NULL
,	NULL
M.	NULL
E.	NULL
Hemler	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
T.	NULL
J.	NULL
Palker	NULL
,	NULL
R.	NULL
M.	NULL
Scearce	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Eisenbarth	NULL
.	NULL

1983	NULL
.	NULL

Differentiation	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

I	NULL
.	NULL

Acquisition	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
cell	NULL
surface	NULL
protein	NULL
(	NULL
p80	NULL
)	NULL
during	NULL
normal	NULL
intrathymic	NULL
T	NULL
cell	NULL
maturation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

131:1195	NULL
.	NULL

Denning	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
T.	NULL
Le	NULL
,	NULL
K.	NULL
H.	NULL
Singer	NULL
,	NULL
and	NULL
B.	NULL
F.	NULL
Haynes	NULL
.	NULL

1990	NULL
.	NULL

Antibodies	NULL
against	NULL
the	NULL
CD44	NULL
p80	NULL
,	NULL
lymphocyte	NULL
homing	NULL
receptor	NULL
molecule	NULL
augment	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:7	NULL
.	NULL

Singla	NULL
,	NULL
S.	NULL
K.	NULL
1987	NULL
.	NULL

Nomenclature	NULL
of	NULL
hyaluronic	NULL
acid	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

242:623	NULL
.	NULL

Laurent	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Fraser	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
properties	NULL
and	NULL
turnover	NULL
of	NULL
hyaluronan	NULL
.	NULL

Ciba	NULL
Found	NULL
.	NULL

Symp	NULL
.	NULL

124:9	NULL
.	NULL

Ng	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
C.	NULL
J.	NULL
Handley	NULL
,	NULL
R.	NULL
M.	NULL
Mason	NULL
,	NULL
and	NULL
H.	NULL
C.	NULL
Robinson	NULL
.	NULL

1989	NULL
.	NULL

Synthesis	NULL
of	NULL
hyaluronate	NULL
in	NULL
cultured	NULL
bovine	NULL
articular	NULL
cartilage	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

263:761	NULL
.	NULL

Wells	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
L.	NULL
Klareskog	NULL
,	NULL
S.	NULL
Lindblad	NULL
,	NULL
and	NULL
T.	NULL
C.	NULL
Laurent	NULL
.	NULL

1992	NULL
.	NULL

Correlation	NULL
between	NULL
increased	NULL
hyaluronan	NULL
localized	NULL
in	NULL
arthritic	NULL
synovium	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
proliferating	NULL
cells	NULL
:	NULL
a	NULL
role	NULL
for	NULL
macrophage-derived	NULL
factors	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

35	NULL
:	NULL
391	NULL
.	NULL

Balazs	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
D.	NULL
Watson	NULL
,	NULL
I.	NULL
F.	NULL
Duff	NULL
,	NULL
and	NULL
S.	NULL
Roseman	NULL
.	NULL

1967	NULL
.	NULL

Hyaluronic	NULL
acid	NULL
in	NULL
synovial	NULL
fluid	NULL
.	NULL

I.	NULL
Molecular	NULL
parameters	NULL
of	NULL
hyaluronic	NULL
acid	NULL
in	NULL
normal	NULL
and	NULL
arthritis	NULL
human	NULL
fluids	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

10:357	NULL
.	NULL

Dahl	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
I.	NULL
M.	NULL
Dahl	NULL
,	NULL
L.	NULL
A.	NULL
Engstrom	NULL
,	NULL
and	NULL
K.	NULL
Granath	NULL
.	NULL

1985	NULL
.	NULL

Concentration	NULL
and	NULL
molecular	NULL
weight	NULL
of	NULL
sodium	NULL
hyaluronate	NULL
in	NULL
synovial	NULL
fluid	NULL
from	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
other	NULL
arthropathies	NULL
.	NULL

Amn	NULL
.	NULL

Rheum	NULL
.	NULL

Dis	NULL
.	NULL

44:817	NULL
.	NULL

Prehm	NULL
,	NULL
P.	NULL
1990	NULL
.	NULL

Release	NULL
of	NULL
hyaluronate	NULL
from	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

267	NULL
;	NULL
185	NULL
.	NULL

Greenwald	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Moy	NULL
.	NULL

1980	NULL
.	NULL

Effect	NULL
of	NULL
oxygen-derived	NULL
free	NULL
radicals	NULL
on	NULL
hyaluronic	NULL
acid	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

23:455	NULL
.	NULL

McNeil	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
O.	NULL
W.	NULL
Wicbkin	NULL
,	NULL
W.	NULL
H.	NULL
Betts	NULL
,	NULL
and	NULL
L.	NULL
G.	NULL
Cleland	NULL
.	NULL

1985	NULL
.	NULL

Depoly-merization	NULL
products	NULL
of	NULL
hyaluronic	NULL
acid	NULL
after	NULL
exposure	NULL
to	NULL
oxygen-derived	NULL
free	NULL
radicals	NULL
.	NULL

Ann	NULL
.	NULL

Rheum	NULL
.	NULL

Dis	NULL
.	NULL

44:780	NULL
.	NULL

Goldberg	NULL
,	NULL
R.	NULL
L..	NULL
,	NULL
and	NULL
B.	NULL
P.	NULL
Toole	NULL
.	NULL

1987	NULL
.	NULL

Hyaluronate	NULL
inhibition	NULL
of	NULL
cell	NULL
prolifer-ation	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

30:769	NULL
.	NULL

Anastassiades	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
W.	NULL
Robertson	NULL
.	NULL

1984	NULL
.	NULL

Modulation	NULL
of	NULL
mitogen-dependent	NULL
lymphocyte	NULL
stimulation	NULL
by	NULL
hyaluronic	NULL
acid	NULL
.	NULL

J.	NULL
Rheumatol	NULL
.	NULL

11:729	NULL
.	NULL

Forrester	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Balazs	NULL
.	NULL

1980	NULL
.	NULL

Inhibition	NULL
of	NULL
phagocytosis	NULL
by	NULL
high	NULL
molecular	NULL
weight	NULL
hyaluronate	NULL
.	NULL

Immunology	NULL
40:435	NULL
.	NULL

Abigren	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
C.	NULL
Jarstrand	NULL
.	NULL

1984	NULL
.	NULL

Hyaluronic	NULL
acid	NULL
enhances	NULL
phagocytosis	NULL
of	NULL
human	NULL
monocytes	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

4:246	NULL
.	NULL

West	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
I.	NULL
N.	NULL
Hampson	NULL
,	NULL
F.	NULL
Arnold	NULL
,	NULL
and	NULL
S.	NULL
Kumar	NULL
.	NULL

1985	NULL
.	NULL

Angiogenesis	NULL
induced	NULL
by	NULL
degradation	NULL
products	NULL
of	NULL
hyaluronic	NULL
acid	NULL
.	NULL

Science	NULL
228:1324	NULL
.	NULL

Oostendorp	NULL
,	NULL
R.	NULL
A.	NULL
J.	NULL
,	NULL
E.	NULL
Spitzer	NULL
,	NULL
and	NULL
P.	NULL
Dormer	NULL
.	NULL

1996	NULL
.	NULL

Adhesion	NULL
of	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
to	NULL
bone-marrow-derived	NULL
stromal	NULL
cells	NULL
is	NULL
enhanced	NULL
by	NULL
antibodies	NULL
to	NULL
CD44	NULL
.	NULL

Acta	NULL
Haematol	NULL
.	NULL

95:243	NULL
.	NULL

Bendall	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
J.	NULL
Kirkness	NULL
,	NULL
A.	NULL
Hutchinson	NULL
,	NULL
A.	NULL
Bianchi	NULL
,	NULL
V.	NULL
Makrynikola	NULL
,	NULL
K.	NULL
F.	NULL
Bradstock	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Gottlieb	NULL
.	NULL

1997	NULL
.	NULL

Antibodies	NULL
to	NULL
CD44	NULL
enhance	NULL
adhesion	NULL
of	NULL
normal	NULL
CD34~	NULL
cells	NULL
and	NULL
acute	NULL
myeloblastic	NULL
but	NULL
not	NULL
lymphoblastic	NULL
leukemia	NULL
cells	NULL
to	NULL
bone	NULL
marrow	NULL
stroma	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

98:828	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2398	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1990	NULL
.	NULL

Adhesion	NULL
receptors	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Nature	NULL
346	NULL
:	NULL
425	NULL
.	NULL

Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
L.	NULL
P.	NULL
Hale	NULL
,	NULL
S.	NULL
M.	NULL
Denning	NULL
,	NULL
P.	NULL
T.	NULL
Le	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Singer	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
role	NULL
of	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
in	NULL
cellular	NULL
interactions	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammatory	NULL
synovitis	NULL
.	NULL

Springer	NULL
Semin	NULL
.	NULL

Immu-nopathol	NULL
.	NULL

11:163	NULL
.	NULL

Hemler	NULL
,	NULL
M.	NULL
E.	NULL
1988	NULL
.	NULL

Adhesive	NULL
protein	NULL
receptors	NULL
on	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
9:109	NULL
.	NULL

Damle	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
A.	NULL
Aruffo	NULL
.	NULL

1991	NULL
.	NULL

Vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
induces	NULL
T-cell	NULL
antigen	NULL
receptor-dependent	NULL
activation	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:6403	NULL
.	NULL

Van	NULL
Seventer	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
Y.	NULL
Shimizu	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
K.	NULL
J.	NULL
Horgan	NULL
,	NULL
T.	NULL
Nutman	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
three	NULL
activation	NULL
regulated	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
and	NULL
ELAM-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:901	NULL
.	NULL

Muller	NULL
,	NULL
L.	NULL
U.	NULL
,	NULL
J.	NULL
Kriegsmann	NULL
,	NULL
B.	NULL
N.	NULL
Franklin	NULL
,	NULL
S.	NULL
Matsumoto	NULL
,	NULL
T.	NULL
Geiler	NULL
,	NULL
R.	NULL
E.	NULL
Gay	NULL
,	NULL
and	NULL
S.	NULL
Gay	NULL
.	NULL

1996	NULL
.	NULL

Synovial	NULL
fibroblasts	NULL
of	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
attach	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

VCAM-1	NULL
INDUCTION	NULL
BY	NULL
CD44	NULL
to	NULL
and	NULL
invade	NULL
normal	NULL
human	NULL
cartilage	NULL
when	NULL
engrafted	NULL
into	NULL
SCID	NULL
mice	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

149:1607	NULL
.	NULL

Cybulsky	NULL
,	NULL
M.	NULL
L	NULL
,	NULL
J.	NULL
W.	NULL
Fries	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
P.	NULL
Sultan	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
M.	NULL
Byers	NULL
,	NULL
T.	NULL
Shows	NULL
,	NULL
M.	NULL
J.	NULL
Gimbrone	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1991	NULL
.	NULL

Gene	NULL
structure	NULL
,	NULL
chromosomal	NULL
location	NULL
,	NULL
and	NULL
basis	NULL
for	NULL
alternative	NULL
mRNA	NULL
splicing	NULL
of	NULL
the	NULL
human	NULL
VCAM-1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7859	NULL
.	NULL

Marui	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
K.	NULL
Offermann	NULL
,	NULL
R.	NULL
Swerlick	NULL
,	NULL
C.	NULL
Kunsch	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
M.	NULL
Ahmad	NULL
,	NULL
R.	NULL
W.	NULL
Alexander	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Medford	NULL
.	NULL

1993	NULL
.	NULL

Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
are	NULL
regulated	NULL
through	NULL
an	NULL
antioxi-dant-sensitive	NULL
mechanism	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92:1866	NULL
.	NULL

Tademarco	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
J.	NULL
McQuillan	NULL
,	NULL
G.	NULL
D.	NULL
Rosen	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16323	NULL
.	NULL

Neish	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
H.	NULL
J.	NULL
Palmer	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1583	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

